<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00937326</url>
  </required_header>
  <id_info>
    <org_study_id>113160</org_study_id>
    <nct_id>NCT00937326</nct_id>
  </id_info>
  <brief_title>Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects</brief_title>
  <official_title>A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sirtris, a GSK Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to determine the safety and tolerability of SRT2104
      (0.25, 0.5, 1.0, and 2.0 g/day) in type 2 diabetic subjects when administered once daily for
      28 consecutive days, and to characterize the pharmacokinetic profile of SRT2104 after a
      single dose and multiple administrations in type 2 diabetic subjects.

      The secondary purpose of this study is to determine the effect of SRT2104 (0.25, 0.5, 1.0,
      and 2.0 g/day) when administered once daily for 28 consecutive days on fasting blood glucose
      and insulin and post-prandial blood glucose and insulin in type 2 diabetic subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objectives

      Primary:

        1. To determine the safety and tolerability of SRT2104 (0.25, 0.5, 1.0, and 2.0 g/day) in
           type 2 diabetic subjects when administered once daily for 28 consecutive days.

        2. To characterize the pharmacokinetic profile of SRT2104 (0.25, 0.5, 1.0, and 2.0 g/day)
           after a single dose and multiple administrations in type 2 diabetic subjects.

      Secondary:

      1. To determine the effect of SRT2104 (0.25, 0.5, 1.0, and 2.0 g/day) when administered once
      daily for 28 consecutive days on fasting blood glucose and insulin and post-prandial blood
      glucose and insulin in type 2 diabetic subjects.

      Study Design:

      Prospective, multi-center, clinical study of SRT2104 administered orally once daily for 28
      consecutive days; randomized, placebo-controlled, double-blind, multiple-dose,
      inpatient/outpatient study to assess the safety and pharmacokinetics (PK) of SRT2104 in type
      2 diabetic male and female subjects on an existing, stable, background metformin therapy.
      Approximately 225 subjects aged 30-70, who fulfill the inclusion/exclusion criteria, will be
      enrolled in this study to ensure completion of forty (40) evaluable subjects within each of
      five dosing groups. Subjects will be evenly randomized to receive SRT2104 at one of five
      doses, placebo (A), 0.25 g/day (B), 0.5 g/day (C), 1.0 g/day (D), or 2.0 g/day (E), once a
      day for 28 consecutive days, approximately 15 minutes following consumption of a standardized
      meal. Subjects will remain on a fixed dose of test material for all dosing days in the study.

      Subjects will sign the informed consent form at the Screening Visit, and will undergo
      screening assessments over a 2-day period to verify eligibility for the study. If eligible
      and willing to participate, subjects will return to the clinic within 21 days of the
      Screening Visit to participate in the dosing phase of the study. Subjects will be randomized
      to receive SRT2104 or placebo, and will be required to stay overnight at the study center on
      Day -1 and Day 27 to gather required PK samples and to assess safety on Day 1 and Day 28
      respectively. In addition, subjects will be asked to return to the study center on Days 2 and
      29; for three interim weekly safety assessments (on Days 8, 15, 22); and for an End of Study
      safety assessment 7 days after they complete the 28-day dosing period. A follow-up safety
      call will be made to each subject 30 days following their final dose of SRT2104 or placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 19, 2009</start_date>
  <completion_date type="Actual">September 18, 2010</completion_date>
  <primary_completion_date type="Actual">September 18, 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Any Adverse Event (AE), Serious Adverse Event (SAE), AE Related to Study Medication, AE Leading to Discontinuation and Fatal AE of Death</measure>
    <time_frame>Up to Follow-up (58 days)</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, or is a congenital anomaly/birth defect, may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed in this definition. AE's were classified as related to the study medication, based on the investigator's judgment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With AE by Intensity of Mild, Moderate and Severe</measure>
    <time_frame>Up to Follow-up (58 days)</time_frame>
    <description>Intensity for each AE was categorized as mild, moderate and severe. Mild was defined as awareness of sign or symptom, but easily tolerated; moderate was defined as discomfort enough to cause interference with normal daily activities; severe was defined as inability to perform normal daily activities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Change From Baseline in Weight Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Participant's body weight was assessed in the beginning of the study (at Day 1) and at the end of the study (Day 28 and Day 35). The clinical staff was instructed to use calibrated scales for weight measurement. The same scale was used at the clinical site for all participants at each specified time point during the study. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Vital Sign Parameter of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Over Time</measure>
    <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
    <description>Vital sign assessment of SBP and DBP was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Vital Sign Parameter of Heart Rate (HR) Over Time</measure>
    <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
    <description>Vital sign assessment of HR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Vital Sign Parameter of Respiratory Rate (RR) Over Time</measure>
    <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
    <description>Vital sign assessment of RR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Vital Sign Parameter of Temperature Over Time</measure>
    <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
    <description>Vital sign assessment of temperature was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Electrocardiogram (ECG) Values Over Time</measure>
    <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
    <description>12-lead ECG was obtained in the rested state. Participants lied in supine position with ECG leads on for at least 5 minutes prior to ECG recording. The ECG was performed at Day 1 (pre-dose and post-dose), Day 8, Day 15, Day 22, Day 28 (pre-dose and pre-dose) and Day 35, and included the assessment of PR interval, QRS interval, QT interval and QTc interval. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1 [post-dose], Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameters of Basophils, Eosinophils, Lymphocytes, Monocytes, Neutrophils, Platelet and White Blood Cell (WBC) Count Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for basophils, eosinophils, lymphocytes, monocytes, neutrophils, platelet and white blood cell (WBC) count were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Red Blood Cell (RBC) Count Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for RBC count was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Hematocrit Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for hematocrit was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Hemoglobin Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for mean corpuscular hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Concentration Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for mean corpuscular hemoglobin concentration was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hematology Parameter of Mean Corpuscular Volume Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for mean corpuscular volume was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Coagulation Parameters of Activated Partial Thromplastin Time (aPTT) and Prothrombin Time (PT) Over Time</measure>
    <time_frame>Baseline (Day 1), Day 28 and Day 35</time_frame>
    <description>Assessment for aPTT and PT were performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Coagulation Parameter of International Normalized Ratio Over Time</measure>
    <time_frame>Baseline (Day 1), Day 28 and Day 35</time_frame>
    <description>Assessment for international normalized ratio was performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Chemistry Parameters of Alanine Aminotransferase (ALT), Aspartate Aminotrasferase (AST), Alkaline Phosphatase (ALP), Creatinine Phosphokinase and Lactate Dehydrogenase (LDH) Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for ALT, AST, ALP, creatinine phosphokinase and LDH were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Chemistry Parameter of Bicarbonate, Blood Urea Nitrogen (BUN), Calcium, Chloride, Magnesium, Phosphate, Potassium and Sodium Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for bicarbonate, BUN, calcium, chloride, magnesium, phosphate, potassium and sodium were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Chemistry Parameter of Direct Bilirubin, Indirect Bilirubin, Serum Creatinine, Total Bilirubin and Uric Acid Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for direct bilirubin, indirect bilirubin, serum creatinine, total bilirubin and uric acid were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Chemistry Parameter of Lipid Profile Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for lipid profile was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. The parameters included high density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol and triglycerides. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Chemistry Parameter of Albumin and Total Protein Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Assessment for albumin and total protein were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Urinalysis Parameter of Specific Gravity Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Urinary specific gravity is a measure of the concentration of solutes in urine. It measures the ratio of urine density compared with water density and provides information on the kidney's ability to concentrate urine. The assessments were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Urinalysis Parameter of pH Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>Urinalysis parameter included urine pH. pH was calculated on a scale of 0 to 14, such that, the lower the number, more acidic the urine and higher the number, more alkaline the urine with 7 being neutral. The assessment was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under Plasma Concentration Curve From Time 0 to Last Measurable Time Point (AUC 0-t), From Time 0 to Infinity (AUC 0-infinity) and From Time 0 to Trough Concentration (AUC 0-τ) of SRT2104 on Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28)</time_frame>
    <description>The pre-dose blood samples were collected within one hour prior to study medication administration. The post-dose blood samples were collected within 2 minutes of the scheduled time. AUC values reported in the analysis of AUC 0-infinity of Day 28 versus Day 1 included AUC 0-infinity on Day 1 and AUC 0-τ on Day 28. Participants fasted for at least 10 hour overnight on Day 1, 2 and 29. The AUC 0-t was determined using the linear trapezoidal rule for increasing concentrations and the logarithmic trapezoidal rule for decreasing concentrations. AUC0-infinity was estimated by linear trapezoidal rule and was sum of the AUC0-t and extrapolated to infinity by dividing the estimated last measurable plasma concentration by elimination rate constant lambda z. Where lambda z is the terminal phase rate constant estimated by linear regression analysis of the log10 transformed concentration-time data after each single dose. The AUC0-infinity was the sum of the estimated and extrapolated parts.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Maximum Plasma Concentration (Cmax) of SRT2104 at Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
    <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. On Day 1, Day 2 and Day 29, participants fasted for at least 10 hour overnight. The post-dose sample was collected within 2 minutes of the scheduled time. The first occurrence of the Cmax was determined directly from the raw concentration-time data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Cmax (Tmax) at Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
    <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. The time at which Cmax was observed was determined directly from the raw concentration-time data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Terminal Elimination Half Life (T1/2) of SRT2104 at Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
    <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight. The t1/2 was obtained as the ratio of ln2/λz, where λz is the terminal phase rate constant estimated by linear regression analysis of the concentration-time data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apparent Total Clearance of SRT2104 From Plasma After Oral Administration (CL/F) on Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
    <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apparent Volume of Distribution After Oral Administration (Vd/F) at Day 1 and Day 28</measure>
    <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
    <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Fasting Plasma Glucose (FPG) Levels Over Time</measure>
    <time_frame>Up to Day 35</time_frame>
    <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in FPG Levels Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Fasting Plasma Insulin (FPI) Levels Over Time</measure>
    <time_frame>Up to Day 35</time_frame>
    <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in FPI Over Time</measure>
    <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
    <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Post-prandial Glucose (PPG) and Post-prandial Insulin (PPI) Levels at Day 28</measure>
    <time_frame>Day 28</time_frame>
    <description>The assessment of PPG and PPI was performed on Day 28 at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in PPG and PPI Levels at Day 28</measure>
    <time_frame>Baseline (Day 1) and Day 28</time_frame>
    <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. Baseline for PPG was defined as the assessment value of FPG done on Day 1 and Baseline for PPI was defined as the assessment value of FPI done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (30 min, 60 min and 2 h at Day 28) values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Glycosylated Hemoglobin A (HbA1c) Levels on Day 28</measure>
    <time_frame>Day 28</time_frame>
    <description>The sample for HbA1c assessment was collected on Day 28. HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HbA1c Levels at Day 28</measure>
    <time_frame>Baseline (Day 1) and Day 28</time_frame>
    <description>HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months. The sample for HbA1c assessment was collected on Day 1 and Day 28. Baseline value was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC From Time 0 to 1 h (AUC 0-1) and AUC From Time 0 to 2 h (AUC 0-2) for PPG and PPI at Day 1 and Day 28</measure>
    <time_frame>Day 1 (30 minutes, 60 minutes and 2 hour) and Day 28 (30 minutes, 60 minutes and 2 hour)</time_frame>
    <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minnutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. AUC with respect to these time interval was calculated using the linear trapezoidal rule by the sum of the areas between each chronological pair of assessments (using observed times) for PPG and PPI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Fructosamine Levels at Day 1 and Day 28</measure>
    <time_frame>Day 1 and Day 28</time_frame>
    <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Fructosamine Levels at Day 28</measure>
    <time_frame>Baseline (Day 1) and Day 28</time_frame>
    <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Homeostatic Model Assessment-insulin Resistance (HOMA-IR) at Day 1 and Day 28</measure>
    <time_frame>Day 1 and Day 28</time_frame>
    <description>HOMA-IR was derived from FPG and FPI as: FPI (micro units [mU]/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HOMA-IR at Day 28</measure>
    <time_frame>Baseline (Day 1) and Day 28</time_frame>
    <description>HOMA-IR was derived from FPG and FPI as: FPI (mU/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean HOMA-percentage Cell Beta Function at Day 1 and Day 28</measure>
    <time_frame>Day 1 and Day 28</time_frame>
    <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HOMA-percentage of Beta Cell Function at Day 28</measure>
    <time_frame>Baseline (Day 1) and Day 28</time_frame>
    <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as assessment done on Day 1. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">227</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The Placebo treatment group will be administered eight placebo capsules per day.
Placebo will be administered orally once daily for twenty-eight consecutive days. Dosing will take place at approximately the same time every morning, approximately 15 minutes following consumption of a standardized meal and should be administered with approximately 1 to 2 glasses of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm1 - 0.25g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 0.25g SRT2104 treatment group will be administered one SRT2104 capsules with 7 placebo capsules, for a total of 8 capsules per day.
0.25g SRT2104 will be administered orally once daily for twenty-eight consecutive days. Dosing will take place at approximately the same time every morning, 15 minutes following consumption of a standardized meal and should be administered with approximately 1 to 2 glasses of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm2 - 0.5g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 0.5g SRT2104 treatment group will be administered two SRT2104 capsules with 6 placebo capsules, for a total of 8 capsules per day.
0.5g SRT2104 will be administered orally once daily for twenty-eight consecutive days. Dosing will take place at approximately the same time every morning, 15 minutes following consumption of a standardized meal and should be administered with approximately 1 to 2 glasses of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm3 - 1g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 1g SRT2104 treatment group will be administered four SRT2104 capsules with four placebo capsules, for a total of 8 capsules per day.
1g SRT2104 will be administered orally once daily for twenty-eight consecutive days. Dosing will take place at approximately the same time every morning, 15 minutes following consumption of a standardized meal and should be administered with approximately 1 to 2 glasses of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm4 - 2g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 2g SRT2104 treatment group will be administered eight SRT2104 capsules per day.
2g SRT2104 will be administered orally once daily for twenty-eight consecutive days. Dosing will take place at approximately the same time every morning, 15 minutes following consumption of a standardized meal and should be administered with approximately 1 to 2 glasses of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SRT2104</intervention_name>
    <description>SRT2104 will be supplied as hard gelatin capsules, with each containing 250 mg.</description>
    <arm_group_label>Arm3 - 1g</arm_group_label>
    <arm_group_label>Arm4 - 2g</arm_group_label>
    <arm_group_label>Arm2 - 0.5g</arm_group_label>
    <arm_group_label>Arm1 - 0.25g</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo will be supplied as hard gelatin capsules, with each containing an appropriate amount of placebo.</description>
    <arm_group_label>Arm3 - 1g</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Arm2 - 0.5g</arm_group_label>
    <arm_group_label>Arm1 - 0.25g</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects of any race and gender within the age range of 30 to 70 years.

          2. All female subjects must be of non-child-bearing potential. For the purposes of this
             study, this is defined as the subject being amenorrheic for at least 12 consecutive
             months, or at least 6 weeks post-surgical bilateral oophorectomy with or without
             hysterectomy, or women who underwent tubal ligation. Menopausal status will be
             confirmed by demonstrating levels of follicle stimulating hormone (FSH) 40 - 138
             mIU/ml and oestradiol &lt; 20 pg/ml at entry, unless this information is available in the
             subject's medical record. In the event a subject's menopause status has been clearly
             established (for example, the subject indicates she has been amenorrheic for 10
             years), but FSH and/or oestradiol levels are not consistent with a post-menopausal
             condition, determination of subject eligibility will be at the discretion of the
             principal investigator following consultation with the sponsor and medical monitor

          3. All male subjects must agree with their partners to use double-barrier birth control
             or abstinence while participating in the study and for 12 weeks following the last
             dose of study drug.

          4. Willingness to provide written informed consent to participate in the study

          5. HbA1c ≥ 7.5 and ≤ 10.5

          6. Fasting glucose ≥ 160 and ≤ 240 mg/dL

          7. Body Mass Index (BMI) ≥ 25.0 kg/m^2 and ≤ 40.0 kg/m^2

          8. On stable metformin medication for at least 3 months (≥ 1.0 g/day) prior to Screening

          9. No prior history of HIV 1 or 2

         10. Absence of disease markers for hepatitis B &amp; C virus

         11. Absence of significant disease or clinically significant abnormal laboratory values on
             the laboratory evaluations, medical history or physical examination during the
             screening; normal end organ function

         12. Have a normal 12-lead ECG or one with abnormality considered to be clinically
             insignificant

         13. Have a normal chest X-ray (P. A. View) or one with abnormality considered to be
             clinically insignificant

         14. Comprehension of the nature and purpose of the study and compliance with the
             requirement of the entire protocol

        Exclusion Criteria:

          1. Any major illness in the past three months or any significant ongoing chronic medical
             illness not related to diabetes

          2. Renal or liver impairment, defined as serum creatinine level of ≥ 1.4 mg/dL for
             females and ≥ 1.5 mg/dL for males, and greater than two times the upper limit of
             normal for liver enzymes, respectively.

          3. History of or current gastro-intestinal diseases influencing drug absorption, except
             for appendectomy

          4. History, within 3 years, of drug abuse (including Benzodiazepines, opioids,
             amphetamine, cocaine, and THC)

          5. History of alcoholism (more than two years), moderate drinkers (more than three drinks
             per day) or having consumed alcohol within 48 hrs prior to dosing [one drink is equal
             to one unit of alcohol (one glass wine, half pint beer, one measure of spirit)]

          6. Participation in any clinical trial within the past three months

          7. History of difficulty in donating blood or accessibility of veins in left or right arm

          8. Donation of blood (one unit or 350 ml) within three months prior to receiving the
             first dose of test material

          9. Use of any prescription drug therapy, with exception of any prescription medication
             administered at a stable dose for at least 6 weeks prior to Screening, provided the
             medication is not contraindicated by the metformin label

         10. Use of any alternate anti-diabetic therapy, except metformin, within three months of
             enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Byala</city>
        <zip>7100</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dimitrovgrad</city>
        <zip>6400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Haskovo</city>
        <zip>6300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tallinn</city>
        <zip>10617</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Balantonfured</city>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Eger</city>
        <zip>3300</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gyula</city>
        <zip>5701</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kecskemet</city>
        <zip>6000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sopron</city>
        <zip>9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Szekszard</city>
        <zip>7100</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cieszyn</city>
        <zip>43-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lubin</city>
        <zip>20-090</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lubin</city>
        <zip>59-301</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pulawy</city>
        <zip>24-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Radzymin</city>
        <zip>05-250</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ruda Slaska</city>
        <zip>41-709</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Slupsk</city>
        <zip>76-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tychy</city>
        <zip>43-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>04-141</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bacau</city>
        <zip>600114</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Braila</city>
        <zip>810249</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buzau</city>
        <zip>120257</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Constanta</city>
        <zip>900591</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oradea</city>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ploiesti</city>
        <zip>100097</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300456</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <zip>656024</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650061</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115 280</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119881</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>121069</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>127486</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>190103</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St.-Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tumen</city>
        <zip>625023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ufa</city>
        <zip>450071</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mykolaiv</city>
        <zip>54003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Simferopol</city>
        <zip>95017</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ternopil</city>
        <zip>46001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vinnitsa</city>
        <zip>21010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhya</city>
        <zip>69001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhya</city>
        <zip>69035</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>London</city>
        <zip>SE 1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Newport</city>
        <zip>PO30 5TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Estonia</country>
    <country>Hungary</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.clinicalstudydatarequest.com</url>
    <description>Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2009</study_first_submitted>
  <study_first_submitted_qc>July 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <results_first_submitted>August 31, 2017</results_first_submitted>
  <results_first_submitted_qc>August 31, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2018</results_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Annotated Case Report Form</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Dataset Specification</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113160</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was planned on 225 male and female participants with type 2 diabetes (T2D) on an existing, stable, background metformin therapy, aged 30 to 70 years, at 45 centers of Bulgaria (7), Estonia (1), Hungary (4), Poland (4), Romania (6), Russia (13), United Kingdom (3) and Ukraine (7) from 19 August 2009 to 18 September 2010.</recruitment_details>
      <pre_assignment_details>Out of 527 participants screened, 227 with glycosylated hemoglobin A (HbA1c) of &gt;=7.5% and &lt;= 10.5% and a fasting glucose (FG) &gt;=160 and &lt;=240 milligram per deciliter (mg/dL) were randomized in 1:1:1:1:1 to oral dose of placebo or any one of 4 doses of SRT2104 (0.25, 0.5, 1.0 or 2.0 gram per day [g/day]), once a day for 28 consecutive days.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 minutes (min) following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="P2">
          <title>SRT2104 0.25 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="P3">
          <title>SRT2104 0.5 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="P4">
          <title>SRT2104 1.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="P5">
          <title>SRT2104 2.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="46"/>
                <participants group_id="P4" count="45"/>
                <participants group_id="P5" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="42"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Chest X-ray showed a suspicious shadow</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="B2">
          <title>SRT2104 0.25 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="B3">
          <title>SRT2104 0.5 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="B4">
          <title>SRT2104 1.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="B5">
          <title>SRT2104 2.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="46"/>
            <count group_id="B4" value="45"/>
            <count group_id="B5" value="45"/>
            <count group_id="B6" value="227"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.8" spread="8.40"/>
                    <measurement group_id="B2" value="58.2" spread="8.04"/>
                    <measurement group_id="B3" value="57.7" spread="9.00"/>
                    <measurement group_id="B4" value="57.3" spread="8.95"/>
                    <measurement group_id="B5" value="55.9" spread="9.03"/>
                    <measurement group_id="B6" value="57.0" spread="8.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="18"/>
                    <measurement group_id="B6" value="126"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="27"/>
                    <measurement group_id="B6" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="45"/>
                    <measurement group_id="B5" value="44"/>
                    <measurement group_id="B6" value="225"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Any Adverse Event (AE), Serious Adverse Event (SAE), AE Related to Study Medication, AE Leading to Discontinuation and Fatal AE of Death</title>
        <description>An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, or is a congenital anomaly/birth defect, may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed in this definition. AE's were classified as related to the study medication, based on the investigator's judgment.</description>
        <time_frame>Up to Follow-up (58 days)</time_frame>
        <population>Safety Analysis Set (SAF) Population was defined as all participants who received at least one dose of any test material during the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Any Adverse Event (AE), Serious Adverse Event (SAE), AE Related to Study Medication, AE Leading to Discontinuation and Fatal AE of Death</title>
          <description>An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, or is a congenital anomaly/birth defect, may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed in this definition. AE's were classified as related to the study medication, based on the investigator's judgment.</description>
          <population>Safety Analysis Set (SAF) Population was defined as all participants who received at least one dose of any test material during the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any AE related to study medication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any AE leading to discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any fatal AE of death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day in number of participants with AE.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4816</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day in number of participants with AE.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1147</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day in number of participants with AE.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0000</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day in number of participants with AE.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4816</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With AE by Intensity of Mild, Moderate and Severe</title>
        <description>Intensity for each AE was categorized as mild, moderate and severe. Mild was defined as awareness of sign or symptom, but easily tolerated; moderate was defined as discomfort enough to cause interference with normal daily activities; severe was defined as inability to perform normal daily activities.</description>
        <time_frame>Up to Follow-up (58 days)</time_frame>
        <population>Safety Analysis Set Population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With AE by Intensity of Mild, Moderate and Severe</title>
          <description>Intensity for each AE was categorized as mild, moderate and severe. Mild was defined as awareness of sign or symptom, but easily tolerated; moderate was defined as discomfort enough to cause interference with normal daily activities; severe was defined as inability to perform normal daily activities.</description>
          <population>Safety Analysis Set Population.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mild AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Change From Baseline in Weight Over Time</title>
        <description>Participant’s body weight was assessed in the beginning of the study (at Day 1) and at the end of the study (Day 28 and Day 35). The clinical staff was instructed to use calibrated scales for weight measurement. The same scale was used at the clinical site for all participants at each specified time point during the study. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in Weight Over Time</title>
          <description>Participant’s body weight was assessed in the beginning of the study (at Day 1) and at the end of the study (Day 28 and Day 35). The clinical staff was instructed to use calibrated scales for weight measurement. The same scale was used at the clinical site for all participants at each specified time point during the study. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Kilogram (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="1.25"/>
                    <measurement group_id="O2" value="-0.81" spread="2.21"/>
                    <measurement group_id="O3" value="-1.25" spread="2.06"/>
                    <measurement group_id="O4" value="-0.56" spread="1.68"/>
                    <measurement group_id="O5" value="-1.54" spread="3.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="1.39"/>
                    <measurement group_id="O2" value="-0.91" spread="2.90"/>
                    <measurement group_id="O3" value="-1.32" spread="1.89"/>
                    <measurement group_id="O4" value="-0.86" spread="1.78"/>
                    <measurement group_id="O5" value="-2.74" spread="7.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Vital Sign Parameter of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Over Time</title>
        <description>Vital sign assessment of SBP and DBP was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Vital Sign Parameter of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Over Time</title>
          <description>Vital sign assessment of SBP and DBP was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Millimeter of mercury (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SBP, Day 1, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.49" spread="9.45"/>
                    <measurement group_id="O2" value="1.30" spread="8.36"/>
                    <measurement group_id="O3" value="0.36" spread="5.27"/>
                    <measurement group_id="O4" value="-0.88" spread="5.13"/>
                    <measurement group_id="O5" value="-0.24" spread="5.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.44" spread="7.16"/>
                    <measurement group_id="O2" value="0.02" spread="6.24"/>
                    <measurement group_id="O3" value="1.36" spread="5.59"/>
                    <measurement group_id="O4" value="-0.95" spread="6.05"/>
                    <measurement group_id="O5" value="-1.10" spread="6.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.51" spread="10.03"/>
                    <measurement group_id="O2" value="-0.81" spread="6.78"/>
                    <measurement group_id="O3" value="-0.02" spread="6.33"/>
                    <measurement group_id="O4" value="-1.83" spread="5.68"/>
                    <measurement group_id="O5" value="-1.40" spread="7.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.60" spread="10.25"/>
                    <measurement group_id="O2" value="-0.51" spread="5.51"/>
                    <measurement group_id="O3" value="-1.45" spread="7.30"/>
                    <measurement group_id="O4" value="-1.64" spread="7.51"/>
                    <measurement group_id="O5" value="-2.93" spread="7.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.33" spread="10.78"/>
                    <measurement group_id="O2" value="-1.14" spread="5.58"/>
                    <measurement group_id="O3" value="-1.98" spread="7.22"/>
                    <measurement group_id="O4" value="-1.33" spread="6.61"/>
                    <measurement group_id="O5" value="-2.71" spread="7.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.51" spread="11.38"/>
                    <measurement group_id="O2" value="-1.53" spread="6.52"/>
                    <measurement group_id="O3" value="-0.86" spread="7.33"/>
                    <measurement group_id="O4" value="-3.71" spread="8.71"/>
                    <measurement group_id="O5" value="-2.74" spread="8.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.07" spread="9.19"/>
                    <measurement group_id="O2" value="-0.93" spread="7.06"/>
                    <measurement group_id="O3" value="0.39" spread="6.96"/>
                    <measurement group_id="O4" value="-2.26" spread="8.50"/>
                    <measurement group_id="O5" value="-1.45" spread="7.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.02" spread="12.64"/>
                    <measurement group_id="O2" value="0.02" spread="7.63"/>
                    <measurement group_id="O3" value="0.02" spread="7.78"/>
                    <measurement group_id="O4" value="-0.83" spread="8.30"/>
                    <measurement group_id="O5" value="0.81" spread="8.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 1, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.41" spread="6.11"/>
                    <measurement group_id="O2" value="0.14" spread="4.75"/>
                    <measurement group_id="O3" value="-0.44" spread="5.68"/>
                    <measurement group_id="O4" value="-0.02" spread="5.26"/>
                    <measurement group_id="O5" value="-1.39" spread="6.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 2, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.64" spread="8.49"/>
                    <measurement group_id="O2" value="-0.30" spread="6.49"/>
                    <measurement group_id="O3" value="-1.05" spread="6.85"/>
                    <measurement group_id="O4" value="-0.31" spread="6.79"/>
                    <measurement group_id="O5" value="-2.50" spread="7.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 2, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.81" spread="9.74"/>
                    <measurement group_id="O2" value="-0.47" spread="7.07"/>
                    <measurement group_id="O3" value="-0.54" spread="5.78"/>
                    <measurement group_id="O4" value="-0.40" spread="6.67"/>
                    <measurement group_id="O5" value="-1.45" spread="8.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 2, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.13" spread="8.79"/>
                    <measurement group_id="O2" value="-0.43" spread="6.81"/>
                    <measurement group_id="O3" value="-1.47" spread="5.99"/>
                    <measurement group_id="O4" value="-2.00" spread="6.88"/>
                    <measurement group_id="O5" value="-1.38" spread="6.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 2, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.22" spread="8.67"/>
                    <measurement group_id="O2" value="-0.48" spread="6.24"/>
                    <measurement group_id="O3" value="-1.34" spread="7.33"/>
                    <measurement group_id="O4" value="-1.32" spread="7.67"/>
                    <measurement group_id="O5" value="-0.88" spread="7.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 8, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.83" spread="10.96"/>
                    <measurement group_id="O2" value="-1.63" spread="6.22"/>
                    <measurement group_id="O3" value="0.42" spread="10.22"/>
                    <measurement group_id="O4" value="0.68" spread="9.93"/>
                    <measurement group_id="O5" value="-1.36" spread="8.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 8, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.67" spread="10.94"/>
                    <measurement group_id="O2" value="-1.47" spread="5.50"/>
                    <measurement group_id="O3" value="1.00" spread="7.76"/>
                    <measurement group_id="O4" value="1.20" spread="9.63"/>
                    <measurement group_id="O5" value="-0.73" spread="7.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 8, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.72" spread="9.10"/>
                    <measurement group_id="O2" value="-0.85" spread="6.48"/>
                    <measurement group_id="O3" value="-0.29" spread="7.82"/>
                    <measurement group_id="O4" value="0.33" spread="9.31"/>
                    <measurement group_id="O5" value="-1.92" spread="8.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 8, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.24" spread="10.22"/>
                    <measurement group_id="O2" value="-1.00" spread="5.68"/>
                    <measurement group_id="O3" value="-1.71" spread="7.80"/>
                    <measurement group_id="O4" value="-2.75" spread="10.30"/>
                    <measurement group_id="O5" value="-1.87" spread="7.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 15, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.77" spread="10.88"/>
                    <measurement group_id="O2" value="-0.43" spread="7.22"/>
                    <measurement group_id="O3" value="0.65" spread="8.22"/>
                    <measurement group_id="O4" value="0.76" spread="9.66"/>
                    <measurement group_id="O5" value="0.03" spread="8.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 15, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.16" spread="12.17"/>
                    <measurement group_id="O2" value="-1.15" spread="6.47"/>
                    <measurement group_id="O3" value="0.69" spread="8.67"/>
                    <measurement group_id="O4" value="-0.27" spread="7.89"/>
                    <measurement group_id="O5" value="-1.18" spread="8.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 15, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.56" spread="10.28"/>
                    <measurement group_id="O2" value="-0.61" spread="8.31"/>
                    <measurement group_id="O3" value="0.03" spread="8.98"/>
                    <measurement group_id="O4" value="-1.83" spread="9.16"/>
                    <measurement group_id="O5" value="-1.97" spread="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 15, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.50" spread="10.25"/>
                    <measurement group_id="O2" value="-0.24" spread="6.43"/>
                    <measurement group_id="O3" value="-0.54" spread="7.27"/>
                    <measurement group_id="O4" value="-0.98" spread="9.96"/>
                    <measurement group_id="O5" value="-1.50" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 22, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.07" spread="9.75"/>
                    <measurement group_id="O2" value="-0.67" spread="8.49"/>
                    <measurement group_id="O3" value="-0.53" spread="8.71"/>
                    <measurement group_id="O4" value="-0.08" spread="9.92"/>
                    <measurement group_id="O5" value="0.08" spread="10.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 22, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.77" spread="11.97"/>
                    <measurement group_id="O2" value="-1.46" spread="6.87"/>
                    <measurement group_id="O3" value="-0.57" spread="6.72"/>
                    <measurement group_id="O4" value="0.08" spread="9.18"/>
                    <measurement group_id="O5" value="-1.18" spread="9.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 22, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.03" spread="10.05"/>
                    <measurement group_id="O2" value="-1.56" spread="6.64"/>
                    <measurement group_id="O3" value="-1.77" spread="6.69"/>
                    <measurement group_id="O4" value="-1.10" spread="9.78"/>
                    <measurement group_id="O5" value="-2.05" spread="8.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 22, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.39" spread="9.31"/>
                    <measurement group_id="O2" value="-1.64" spread="6.68"/>
                    <measurement group_id="O3" value="-1.51" spread="8.29"/>
                    <measurement group_id="O4" value="-0.85" spread="9.57"/>
                    <measurement group_id="O5" value="-2.24" spread="9.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 27</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.91" spread="9.87"/>
                    <measurement group_id="O2" value="-0.49" spread="7.74"/>
                    <measurement group_id="O3" value="-0.48" spread="8.68"/>
                    <measurement group_id="O4" value="0.15" spread="9.04"/>
                    <measurement group_id="O5" value="-1.05" spread="8.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.60" spread="10.39"/>
                    <measurement group_id="O2" value="-0.05" spread="7.17"/>
                    <measurement group_id="O3" value="-1.10" spread="9.35"/>
                    <measurement group_id="O4" value="0.70" spread="9.92"/>
                    <measurement group_id="O5" value="-0.90" spread="8.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.58" spread="11.88"/>
                    <measurement group_id="O2" value="-1.86" spread="7.11"/>
                    <measurement group_id="O3" value="-1.21" spread="9.99"/>
                    <measurement group_id="O4" value="-0.63" spread="9.60"/>
                    <measurement group_id="O5" value="-1.56" spread="8.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.07" spread="11.26"/>
                    <measurement group_id="O2" value="-2.65" spread="6.47"/>
                    <measurement group_id="O3" value="-1.69" spread="9.70"/>
                    <measurement group_id="O4" value="-1.43" spread="9.09"/>
                    <measurement group_id="O5" value="-2.44" spread="8.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.74" spread="11.62"/>
                    <measurement group_id="O2" value="-2.78" spread="6.77"/>
                    <measurement group_id="O3" value="-1.26" spread="8.40"/>
                    <measurement group_id="O4" value="-2.13" spread="9.24"/>
                    <measurement group_id="O5" value="-3.85" spread="7.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.07" spread="12.33"/>
                    <measurement group_id="O2" value="-2.65" spread="6.63"/>
                    <measurement group_id="O3" value="-0.98" spread="9.10"/>
                    <measurement group_id="O4" value="-2.90" spread="7.32"/>
                    <measurement group_id="O5" value="-3.21" spread="8.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.33" spread="11.33"/>
                    <measurement group_id="O2" value="-2.84" spread="6.24"/>
                    <measurement group_id="O3" value="-2.60" spread="8.32"/>
                    <measurement group_id="O4" value="-2.03" spread="8.98"/>
                    <measurement group_id="O5" value="-1.79" spread="9.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.28" spread="11.36"/>
                    <measurement group_id="O2" value="-3.16" spread="6.86"/>
                    <measurement group_id="O3" value="-2.21" spread="7.89"/>
                    <measurement group_id="O4" value="-3.48" spread="9.35"/>
                    <measurement group_id="O5" value="-2.21" spread="7.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.51" spread="12.32"/>
                    <measurement group_id="O2" value="-2.11" spread="7.12"/>
                    <measurement group_id="O3" value="-1.45" spread="8.96"/>
                    <measurement group_id="O4" value="-2.83" spread="9.35"/>
                    <measurement group_id="O5" value="-1.85" spread="9.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.95" spread="11.61"/>
                    <measurement group_id="O2" value="-0.97" spread="6.73"/>
                    <measurement group_id="O3" value="-2.14" spread="8.08"/>
                    <measurement group_id="O4" value="-0.75" spread="8.48"/>
                    <measurement group_id="O5" value="-0.82" spread="9.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 28, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.05" spread="11.72"/>
                    <measurement group_id="O2" value="-1.42" spread="6.82"/>
                    <measurement group_id="O3" value="-1.45" spread="7.42"/>
                    <measurement group_id="O4" value="-0.08" spread="8.02"/>
                    <measurement group_id="O5" value="-3.00" spread="8.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.44" spread="12.39"/>
                    <measurement group_id="O2" value="-2.83" spread="7.47"/>
                    <measurement group_id="O3" value="-0.70" spread="8.05"/>
                    <measurement group_id="O4" value="0.37" spread="8.66"/>
                    <measurement group_id="O5" value="-0.51" spread="9.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.12" spread="6.71"/>
                    <measurement group_id="O2" value="-0.42" spread="5.13"/>
                    <measurement group_id="O3" value="-1.41" spread="6.44"/>
                    <measurement group_id="O4" value="-0.38" spread="5.96"/>
                    <measurement group_id="O5" value="-1.55" spread="5.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.37" spread="5.98"/>
                    <measurement group_id="O2" value="-1.05" spread="4.35"/>
                    <measurement group_id="O3" value="-1.73" spread="5.87"/>
                    <measurement group_id="O4" value="-0.29" spread="5.75"/>
                    <measurement group_id="O5" value="-1.88" spread="5.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.70" spread="6.65"/>
                    <measurement group_id="O2" value="-1.09" spread="5.12"/>
                    <measurement group_id="O3" value="-1.89" spread="5.91"/>
                    <measurement group_id="O4" value="-0.95" spread="5.64"/>
                    <measurement group_id="O5" value="-2.83" spread="5.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.74" spread="7.50"/>
                    <measurement group_id="O2" value="-1.26" spread="6.08"/>
                    <measurement group_id="O3" value="-1.66" spread="5.69"/>
                    <measurement group_id="O4" value="-0.45" spread="5.32"/>
                    <measurement group_id="O5" value="-3.55" spread="6.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.74" spread="6.08"/>
                    <measurement group_id="O2" value="-1.28" spread="6.03"/>
                    <measurement group_id="O3" value="-2.57" spread="5.60"/>
                    <measurement group_id="O4" value="-1.81" spread="6.73"/>
                    <measurement group_id="O5" value="-1.76" spread="5.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.86" spread="7.88"/>
                    <measurement group_id="O2" value="-0.77" spread="6.56"/>
                    <measurement group_id="O3" value="-2.00" spread="6.46"/>
                    <measurement group_id="O4" value="-0.90" spread="6.81"/>
                    <measurement group_id="O5" value="-1.69" spread="5.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.16" spread="6.91"/>
                    <measurement group_id="O2" value="-0.56" spread="6.42"/>
                    <measurement group_id="O3" value="-0.73" spread="6.23"/>
                    <measurement group_id="O4" value="-1.98" spread="6.23"/>
                    <measurement group_id="O5" value="-1.52" spread="6.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.40" spread="8.76"/>
                    <measurement group_id="O2" value="-0.16" spread="7.16"/>
                    <measurement group_id="O3" value="-1.64" spread="7.81"/>
                    <measurement group_id="O4" value="-1.24" spread="6.14"/>
                    <measurement group_id="O5" value="-0.38" spread="5.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 1, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.14" spread="6.07"/>
                    <measurement group_id="O2" value="-0.14" spread="6.24"/>
                    <measurement group_id="O3" value="-1.14" spread="6.91"/>
                    <measurement group_id="O4" value="-0.76" spread="6.84"/>
                    <measurement group_id="O5" value="-2.38" spread="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 2, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.24" spread="6.23"/>
                    <measurement group_id="O2" value="-0.28" spread="6.08"/>
                    <measurement group_id="O3" value="-1.02" spread="6.93"/>
                    <measurement group_id="O4" value="-0.90" spread="7.16"/>
                    <measurement group_id="O5" value="-2.33" spread="6.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 2, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.62" spread="7.05"/>
                    <measurement group_id="O2" value="-0.81" spread="5.67"/>
                    <measurement group_id="O3" value="-0.68" spread="6.46"/>
                    <measurement group_id="O4" value="-0.88" spread="7.27"/>
                    <measurement group_id="O5" value="-2.62" spread="5.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 2, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.71" spread="6.37"/>
                    <measurement group_id="O2" value="-0.45" spread="6.74"/>
                    <measurement group_id="O3" value="-1.79" spread="6.99"/>
                    <measurement group_id="O4" value="-1.80" spread="6.99"/>
                    <measurement group_id="O5" value="-2.45" spread="5.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 2, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.65" spread="7.20"/>
                    <measurement group_id="O2" value="-0.18" spread="6.95"/>
                    <measurement group_id="O3" value="-1.68" spread="6.87"/>
                    <measurement group_id="O4" value="-1.10" spread="6.84"/>
                    <measurement group_id="O5" value="-1.80" spread="6.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 8, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.50" spread="8.09"/>
                    <measurement group_id="O2" value="-1.30" spread="6.65"/>
                    <measurement group_id="O3" value="-0.88" spread="7.49"/>
                    <measurement group_id="O4" value="0.02" spread="6.80"/>
                    <measurement group_id="O5" value="-2.05" spread="6.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 8, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.45" spread="9.16"/>
                    <measurement group_id="O2" value="-1.65" spread="6.94"/>
                    <measurement group_id="O3" value="-0.98" spread="7.06"/>
                    <measurement group_id="O4" value="-0.24" spread="5.72"/>
                    <measurement group_id="O5" value="-2.38" spread="4.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 8, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.36" spread="7.19"/>
                    <measurement group_id="O2" value="-1.93" spread="6.43"/>
                    <measurement group_id="O3" value="-1.71" spread="7.10"/>
                    <measurement group_id="O4" value="-0.70" spread="5.89"/>
                    <measurement group_id="O5" value="-2.58" spread="4.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 8, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.03" spread="7.15"/>
                    <measurement group_id="O2" value="-0.93" spread="6.54"/>
                    <measurement group_id="O3" value="-1.61" spread="7.42"/>
                    <measurement group_id="O4" value="-1.63" spread="6.95"/>
                    <measurement group_id="O5" value="-2.16" spread="5.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 15, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.30" spread="8.17"/>
                    <measurement group_id="O2" value="-0.10" spread="7.49"/>
                    <measurement group_id="O3" value="-1.21" spread="6.46"/>
                    <measurement group_id="O4" value="-0.90" spread="6.81"/>
                    <measurement group_id="O5" value="-0.63" spread="6.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 15, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.70" spread="8.54"/>
                    <measurement group_id="O2" value="-0.60" spread="8.26"/>
                    <measurement group_id="O3" value="-0.98" spread="8.15"/>
                    <measurement group_id="O4" value="-1.85" spread="6.57"/>
                    <measurement group_id="O5" value="-1.33" spread="7.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 15, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.33" spread="7.98"/>
                    <measurement group_id="O2" value="-0.05" spread="7.15"/>
                    <measurement group_id="O3" value="-2.15" spread="7.73"/>
                    <measurement group_id="O4" value="-2.39" spread="8.22"/>
                    <measurement group_id="O5" value="-2.37" spread="6.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 15, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.26" spread="5.95"/>
                    <measurement group_id="O2" value="0.92" spread="7.57"/>
                    <measurement group_id="O3" value="-2.23" spread="7.04"/>
                    <measurement group_id="O4" value="-2.07" spread="7.31"/>
                    <measurement group_id="O5" value="-2.24" spread="5.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 22, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.21" spread="6.90"/>
                    <measurement group_id="O2" value="-1.90" spread="6.53"/>
                    <measurement group_id="O3" value="-0.67" spread="6.63"/>
                    <measurement group_id="O4" value="0.63" spread="8.86"/>
                    <measurement group_id="O5" value="-0.44" spread="8.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 22, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.05" spread="8.91"/>
                    <measurement group_id="O2" value="-1.62" spread="6.27"/>
                    <measurement group_id="O3" value="-1.67" spread="8.62"/>
                    <measurement group_id="O4" value="-0.90" spread="8.44"/>
                    <measurement group_id="O5" value="-2.54" spread="7.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 22, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.51" spread="7.91"/>
                    <measurement group_id="O2" value="-2.53" spread="6.60"/>
                    <measurement group_id="O3" value="-1.51" spread="7.44"/>
                    <measurement group_id="O4" value="-0.98" spread="8.78"/>
                    <measurement group_id="O5" value="-1.30" spread="6.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 22, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.89" spread="6.88"/>
                    <measurement group_id="O2" value="-1.36" spread="6.41"/>
                    <measurement group_id="O3" value="-1.31" spread="7.16"/>
                    <measurement group_id="O4" value="-1.35" spread="8.05"/>
                    <measurement group_id="O5" value="-2.89" spread="6.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 27</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.86" spread="7.04"/>
                    <measurement group_id="O2" value="-1.00" spread="7.53"/>
                    <measurement group_id="O3" value="-1.43" spread="6.32"/>
                    <measurement group_id="O4" value="-0.75" spread="6.53"/>
                    <measurement group_id="O5" value="-2.69" spread="6.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.67" spread="6.62"/>
                    <measurement group_id="O2" value="0.14" spread="5.71"/>
                    <measurement group_id="O3" value="-1.31" spread="6.66"/>
                    <measurement group_id="O4" value="0.25" spread="8.23"/>
                    <measurement group_id="O5" value="-1.28" spread="6.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.37" spread="7.42"/>
                    <measurement group_id="O2" value="-1.24" spread="9.26"/>
                    <measurement group_id="O3" value="-1.19" spread="5.58"/>
                    <measurement group_id="O4" value="-0.63" spread="8.20"/>
                    <measurement group_id="O5" value="-1.28" spread="6.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.37" spread="7.25"/>
                    <measurement group_id="O2" value="-0.81" spread="7.23"/>
                    <measurement group_id="O3" value="-1.57" spread="6.01"/>
                    <measurement group_id="O4" value="-1.05" spread="8.90"/>
                    <measurement group_id="O5" value="-2.41" spread="6.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.58" spread="7.11"/>
                    <measurement group_id="O2" value="-2.00" spread="6.94"/>
                    <measurement group_id="O3" value="-1.07" spread="7.63"/>
                    <measurement group_id="O4" value="-1.45" spread="7.37"/>
                    <measurement group_id="O5" value="-3.62" spread="5.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.14" spread="8.05"/>
                    <measurement group_id="O2" value="-2.41" spread="5.89"/>
                    <measurement group_id="O3" value="-0.93" spread="6.69"/>
                    <measurement group_id="O4" value="-2.13" spread="7.57"/>
                    <measurement group_id="O5" value="-2.62" spread="5.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.31" spread="7.58"/>
                    <measurement group_id="O2" value="-2.70" spread="7.08"/>
                    <measurement group_id="O3" value="-2.71" spread="5.26"/>
                    <measurement group_id="O4" value="-2.15" spread="7.83"/>
                    <measurement group_id="O5" value="-1.90" spread="6.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.30" spread="7.23"/>
                    <measurement group_id="O2" value="-1.57" spread="5.51"/>
                    <measurement group_id="O3" value="-2.64" spread="5.92"/>
                    <measurement group_id="O4" value="-2.10" spread="7.73"/>
                    <measurement group_id="O5" value="-2.23" spread="5.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.02" spread="7.16"/>
                    <measurement group_id="O2" value="-1.03" spread="5.91"/>
                    <measurement group_id="O3" value="-1.57" spread="6.91"/>
                    <measurement group_id="O4" value="-1.10" spread="7.73"/>
                    <measurement group_id="O5" value="-1.33" spread="6.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.58" spread="6.27"/>
                    <measurement group_id="O2" value="-1.82" spread="6.56"/>
                    <measurement group_id="O3" value="-1.93" spread="5.85"/>
                    <measurement group_id="O4" value="-0.90" spread="8.45"/>
                    <measurement group_id="O5" value="-0.97" spread="6.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 28, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.40" spread="8.66"/>
                    <measurement group_id="O2" value="-0.71" spread="7.23"/>
                    <measurement group_id="O3" value="-2.38" spread="5.41"/>
                    <measurement group_id="O4" value="-1.35" spread="8.34"/>
                    <measurement group_id="O5" value="-2.21" spread="6.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.07" spread="9.11"/>
                    <measurement group_id="O2" value="-0.69" spread="6.38"/>
                    <measurement group_id="O3" value="-2.33" spread="8.06"/>
                    <measurement group_id="O4" value="0.61" spread="7.29"/>
                    <measurement group_id="O5" value="-1.46" spread="7.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Vital Sign Parameter of Heart Rate (HR) Over Time</title>
        <description>Vital sign assessment of HR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Vital Sign Parameter of Heart Rate (HR) Over Time</title>
          <description>Vital sign assessment of HR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Beats per minute (bpm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="5.82"/>
                    <measurement group_id="O2" value="1.02" spread="5.24"/>
                    <measurement group_id="O3" value="0.23" spread="5.08"/>
                    <measurement group_id="O4" value="1.21" spread="6.32"/>
                    <measurement group_id="O5" value="1.60" spread="4.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="5.99"/>
                    <measurement group_id="O2" value="1.12" spread="5.55"/>
                    <measurement group_id="O3" value="0.47" spread="6.10"/>
                    <measurement group_id="O4" value="1.12" spread="6.06"/>
                    <measurement group_id="O5" value="0.26" spread="5.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="6.16"/>
                    <measurement group_id="O2" value="0.33" spread="5.84"/>
                    <measurement group_id="O3" value="-0.35" spread="6.27"/>
                    <measurement group_id="O4" value="-0.48" spread="7.19"/>
                    <measurement group_id="O5" value="0.43" spread="4.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="5.63"/>
                    <measurement group_id="O2" value="0.09" spread="5.95"/>
                    <measurement group_id="O3" value="-1.16" spread="5.63"/>
                    <measurement group_id="O4" value="-1.19" spread="5.56"/>
                    <measurement group_id="O5" value="0.45" spread="5.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="5.39"/>
                    <measurement group_id="O2" value="0.07" spread="6.25"/>
                    <measurement group_id="O3" value="-1.19" spread="6.50"/>
                    <measurement group_id="O4" value="0.12" spread="6.83"/>
                    <measurement group_id="O5" value="0.19" spread="5.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.37" spread="5.94"/>
                    <measurement group_id="O2" value="-0.53" spread="6.04"/>
                    <measurement group_id="O3" value="-0.40" spread="6.81"/>
                    <measurement group_id="O4" value="-1.81" spread="5.64"/>
                    <measurement group_id="O5" value="0.05" spread="6.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.70" spread="6.00"/>
                    <measurement group_id="O2" value="-0.79" spread="4.29"/>
                    <measurement group_id="O3" value="-0.72" spread="5.15"/>
                    <measurement group_id="O4" value="-2.14" spread="5.26"/>
                    <measurement group_id="O5" value="0.95" spread="5.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.05" spread="6.35"/>
                    <measurement group_id="O2" value="-1.05" spread="4.77"/>
                    <measurement group_id="O3" value="-0.72" spread="6.03"/>
                    <measurement group_id="O4" value="-1.38" spread="5.58"/>
                    <measurement group_id="O5" value="0.45" spread="6.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="5.49"/>
                    <measurement group_id="O2" value="-0.40" spread="5.57"/>
                    <measurement group_id="O3" value="0.14" spread="5.09"/>
                    <measurement group_id="O4" value="-0.19" spread="5.06"/>
                    <measurement group_id="O5" value="0.64" spread="5.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="6.11"/>
                    <measurement group_id="O2" value="0.30" spread="6.06"/>
                    <measurement group_id="O3" value="0.14" spread="5.02"/>
                    <measurement group_id="O4" value="-0.14" spread="4.95"/>
                    <measurement group_id="O5" value="0.81" spread="5.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="5.59"/>
                    <measurement group_id="O2" value="1.00" spread="5.81"/>
                    <measurement group_id="O3" value="-0.12" spread="5.69"/>
                    <measurement group_id="O4" value="0.67" spread="5.85"/>
                    <measurement group_id="O5" value="1.14" spread="5.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="4.97"/>
                    <measurement group_id="O2" value="0.28" spread="5.80"/>
                    <measurement group_id="O3" value="-0.08" spread="6.07"/>
                    <measurement group_id="O4" value="-0.76" spread="5.61"/>
                    <measurement group_id="O5" value="1.03" spread="4.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="4.50"/>
                    <measurement group_id="O2" value="0.18" spread="5.85"/>
                    <measurement group_id="O3" value="-1.13" spread="6.63"/>
                    <measurement group_id="O4" value="-1.29" spread="6.30"/>
                    <measurement group_id="O5" value="1.35" spread="4.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="5.72"/>
                    <measurement group_id="O2" value="-0.84" spread="6.74"/>
                    <measurement group_id="O3" value="1.53" spread="8.69"/>
                    <measurement group_id="O4" value="0.15" spread="7.80"/>
                    <measurement group_id="O5" value="1.36" spread="6.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="5.15"/>
                    <measurement group_id="O2" value="-0.56" spread="6.47"/>
                    <measurement group_id="O3" value="1.12" spread="8.94"/>
                    <measurement group_id="O4" value="-0.07" spread="8.13"/>
                    <measurement group_id="O5" value="1.85" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="5.92"/>
                    <measurement group_id="O2" value="-0.15" spread="6.78"/>
                    <measurement group_id="O3" value="-1.11" spread="7.51"/>
                    <measurement group_id="O4" value="0.30" spread="8.46"/>
                    <measurement group_id="O5" value="1.66" spread="5.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="4.99"/>
                    <measurement group_id="O2" value="-0.35" spread="6.91"/>
                    <measurement group_id="O3" value="-1.26" spread="6.73"/>
                    <measurement group_id="O4" value="-0.93" spread="7.45"/>
                    <measurement group_id="O5" value="1.71" spread="6.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="7.53"/>
                    <measurement group_id="O2" value="-0.53" spread="8.05"/>
                    <measurement group_id="O3" value="0.23" spread="6.79"/>
                    <measurement group_id="O4" value="-1.10" spread="8.42"/>
                    <measurement group_id="O5" value="-0.43" spread="6.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="6.69"/>
                    <measurement group_id="O2" value="-0.55" spread="8.34"/>
                    <measurement group_id="O3" value="0.43" spread="8.14"/>
                    <measurement group_id="O4" value="-1.17" spread="8.44"/>
                    <measurement group_id="O5" value="0.68" spread="6.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.72" spread="6.01"/>
                    <measurement group_id="O2" value="-0.24" spread="8.31"/>
                    <measurement group_id="O3" value="-0.49" spread="8.42"/>
                    <measurement group_id="O4" value="-1.68" spread="8.30"/>
                    <measurement group_id="O5" value="0.82" spread="6.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="5.25"/>
                    <measurement group_id="O2" value="-0.81" spread="7.50"/>
                    <measurement group_id="O3" value="-1.46" spread="7.08"/>
                    <measurement group_id="O4" value="-0.73" spread="8.33"/>
                    <measurement group_id="O5" value="0.13" spread="5.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="7.10"/>
                    <measurement group_id="O2" value="-1.33" spread="8.21"/>
                    <measurement group_id="O3" value="1.33" spread="7.89"/>
                    <measurement group_id="O4" value="-0.50" spread="10.19"/>
                    <measurement group_id="O5" value="1.13" spread="7.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="6.90"/>
                    <measurement group_id="O2" value="-0.59" spread="7.27"/>
                    <measurement group_id="O3" value="0.88" spread="8.50"/>
                    <measurement group_id="O4" value="-0.10" spread="9.16"/>
                    <measurement group_id="O5" value="0.62" spread="6.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="7.02"/>
                    <measurement group_id="O2" value="-1.08" spread="7.69"/>
                    <measurement group_id="O3" value="0.05" spread="8.33"/>
                    <measurement group_id="O4" value="0.53" spread="9.53"/>
                    <measurement group_id="O5" value="0.51" spread="6.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="6.05"/>
                    <measurement group_id="O2" value="-1.03" spread="8.11"/>
                    <measurement group_id="O3" value="0.46" spread="7.45"/>
                    <measurement group_id="O4" value="0.28" spread="9.25"/>
                    <measurement group_id="O5" value="0.03" spread="7.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 27</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.70" spread="6.94"/>
                    <measurement group_id="O2" value="-1.19" spread="8.27"/>
                    <measurement group_id="O3" value="-1.83" spread="6.58"/>
                    <measurement group_id="O4" value="-0.75" spread="8.05"/>
                    <measurement group_id="O5" value="-0.10" spread="5.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.67" spread="6.92"/>
                    <measurement group_id="O2" value="-1.95" spread="6.99"/>
                    <measurement group_id="O3" value="-1.26" spread="5.44"/>
                    <measurement group_id="O4" value="-0.73" spread="9.60"/>
                    <measurement group_id="O5" value="-0.67" spread="5.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.67" spread="7.61"/>
                    <measurement group_id="O2" value="-1.11" spread="7.44"/>
                    <measurement group_id="O3" value="-0.50" spread="6.95"/>
                    <measurement group_id="O4" value="-0.03" spread="10.28"/>
                    <measurement group_id="O5" value="0.31" spread="5.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.60" spread="6.97"/>
                    <measurement group_id="O2" value="-1.84" spread="6.99"/>
                    <measurement group_id="O3" value="-0.12" spread="7.30"/>
                    <measurement group_id="O4" value="-0.43" spread="9.47"/>
                    <measurement group_id="O5" value="0.26" spread="5.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.44" spread="6.55"/>
                    <measurement group_id="O2" value="-1.76" spread="7.03"/>
                    <measurement group_id="O3" value="-1.20" spread="6.75"/>
                    <measurement group_id="O4" value="-1.18" spread="9.58"/>
                    <measurement group_id="O5" value="0.69" spread="6.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.40" spread="6.93"/>
                    <measurement group_id="O2" value="-3.16" spread="6.13"/>
                    <measurement group_id="O3" value="-1.20" spread="6.55"/>
                    <measurement group_id="O4" value="-0.65" spread="9.23"/>
                    <measurement group_id="O5" value="0.21" spread="6.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.55" spread="6.56"/>
                    <measurement group_id="O2" value="-1.97" spread="6.72"/>
                    <measurement group_id="O3" value="-1.46" spread="7.41"/>
                    <measurement group_id="O4" value="-1.53" spread="8.71"/>
                    <measurement group_id="O5" value="0.36" spread="7.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.91" spread="7.33"/>
                    <measurement group_id="O2" value="-2.22" spread="6.94"/>
                    <measurement group_id="O3" value="-1.24" spread="6.40"/>
                    <measurement group_id="O4" value="-1.93" spread="9.45"/>
                    <measurement group_id="O5" value="0.67" spread="7.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="7.47"/>
                    <measurement group_id="O2" value="-2.14" spread="6.29"/>
                    <measurement group_id="O3" value="-1.10" spread="6.87"/>
                    <measurement group_id="O4" value="-1.63" spread="7.88"/>
                    <measurement group_id="O5" value="0.05" spread="7.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.72" spread="7.00"/>
                    <measurement group_id="O2" value="-2.05" spread="6.15"/>
                    <measurement group_id="O3" value="-2.02" spread="7.82"/>
                    <measurement group_id="O4" value="-0.20" spread="8.29"/>
                    <measurement group_id="O5" value="0.54" spread="7.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.58" spread="7.43"/>
                    <measurement group_id="O2" value="-1.50" spread="7.26"/>
                    <measurement group_id="O3" value="-0.60" spread="5.49"/>
                    <measurement group_id="O4" value="-1.33" spread="7.91"/>
                    <measurement group_id="O5" value="-0.92" spread="6.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="7.20"/>
                    <measurement group_id="O2" value="-1.90" spread="6.80"/>
                    <measurement group_id="O3" value="-0.56" spread="6.62"/>
                    <measurement group_id="O4" value="-3.15" spread="8.33"/>
                    <measurement group_id="O5" value="0.56" spread="5.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Vital Sign Parameter of Respiratory Rate (RR) Over Time</title>
        <description>Vital sign assessment of RR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Vital Sign Parameter of Respiratory Rate (RR) Over Time</title>
          <description>Vital sign assessment of RR was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Breaths per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.89"/>
                    <measurement group_id="O2" value="-0.07" spread="1.12"/>
                    <measurement group_id="O3" value="-0.16" spread="1.15"/>
                    <measurement group_id="O4" value="0.33" spread="0.79"/>
                    <measurement group_id="O5" value="0.00" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="1.10"/>
                    <measurement group_id="O2" value="0.05" spread="1.11"/>
                    <measurement group_id="O3" value="0.19" spread="0.96"/>
                    <measurement group_id="O4" value="0.96" spread="1.11"/>
                    <measurement group_id="O5" value="-0.02" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.97"/>
                    <measurement group_id="O2" value="-0.12" spread="0.96"/>
                    <measurement group_id="O3" value="-0.23" spread="1.09"/>
                    <measurement group_id="O4" value="0.10" spread="1.08"/>
                    <measurement group_id="O5" value="0.07" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.26" spread="0.93"/>
                    <measurement group_id="O2" value="0.19" spread="1.14"/>
                    <measurement group_id="O3" value="-0.37" spread="1.11"/>
                    <measurement group_id="O4" value="0.10" spread="1.05"/>
                    <measurement group_id="O5" value="0.21" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.94"/>
                    <measurement group_id="O2" value="0.02" spread="1.01"/>
                    <measurement group_id="O3" value="-0.42" spread="1.10"/>
                    <measurement group_id="O4" value="0.31" spread="1.09"/>
                    <measurement group_id="O5" value="0.17" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="1.09"/>
                    <measurement group_id="O2" value="-0.07" spread="1.01"/>
                    <measurement group_id="O3" value="-0.12" spread="1.12"/>
                    <measurement group_id="O4" value="-0.02" spread="1.18"/>
                    <measurement group_id="O5" value="0.07" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="1.20"/>
                    <measurement group_id="O2" value="-0.02" spread="0.99"/>
                    <measurement group_id="O3" value="-0.26" spread="1.27"/>
                    <measurement group_id="O4" value="0.19" spread="1.09"/>
                    <measurement group_id="O5" value="0.07" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="1.06"/>
                    <measurement group_id="O2" value="-0.05" spread="0.97"/>
                    <measurement group_id="O3" value="-0.16" spread="0.92"/>
                    <measurement group_id="O4" value="0.24" spread="1.05"/>
                    <measurement group_id="O5" value="0.31" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="1.00"/>
                    <measurement group_id="O2" value="0.09" spread="1.25"/>
                    <measurement group_id="O3" value="-0.45" spread="0.90"/>
                    <measurement group_id="O4" value="-0.05" spread="0.76"/>
                    <measurement group_id="O5" value="0.00" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.99"/>
                    <measurement group_id="O2" value="0.09" spread="1.17"/>
                    <measurement group_id="O3" value="-0.40" spread="0.90"/>
                    <measurement group_id="O4" value="-0.02" spread="0.78"/>
                    <measurement group_id="O5" value="0.00" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.89"/>
                    <measurement group_id="O2" value="0.02" spread="0.94"/>
                    <measurement group_id="O3" value="-0.32" spread="1.01"/>
                    <measurement group_id="O4" value="0.10" spread="1.01"/>
                    <measurement group_id="O5" value="-0.02" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="1.01"/>
                    <measurement group_id="O2" value="0.10" spread="1.10"/>
                    <measurement group_id="O3" value="-0.21" spread="0.93"/>
                    <measurement group_id="O4" value="-0.15" spread="1.22"/>
                    <measurement group_id="O5" value="-0.05" spread="1.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.97"/>
                    <measurement group_id="O2" value="0.13" spread="1.09"/>
                    <measurement group_id="O3" value="-0.39" spread="0.97"/>
                    <measurement group_id="O4" value="0.00" spread="0.74"/>
                    <measurement group_id="O5" value="0.10" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="1.33"/>
                    <measurement group_id="O2" value="0.00" spread="1.00"/>
                    <measurement group_id="O3" value="-0.37" spread="1.18"/>
                    <measurement group_id="O4" value="0.24" spread="0.99"/>
                    <measurement group_id="O5" value="-0.21" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="1.08"/>
                    <measurement group_id="O2" value="0.09" spread="1.00"/>
                    <measurement group_id="O3" value="-0.43" spread="1.43"/>
                    <measurement group_id="O4" value="0.24" spread="1.11"/>
                    <measurement group_id="O5" value="-0.08" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="1.04"/>
                    <measurement group_id="O2" value="0.05" spread="1.32"/>
                    <measurement group_id="O3" value="-0.50" spread="1.25"/>
                    <measurement group_id="O4" value="0.35" spread="1.00"/>
                    <measurement group_id="O5" value="-0.08" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="1.11"/>
                    <measurement group_id="O2" value="0.00" spread="1.06"/>
                    <measurement group_id="O3" value="-0.37" spread="1.15"/>
                    <measurement group_id="O4" value="0.08" spread="1.10"/>
                    <measurement group_id="O5" value="0.11" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="1.15"/>
                    <measurement group_id="O2" value="-0.05" spread="1.06"/>
                    <measurement group_id="O3" value="-0.58" spread="1.12"/>
                    <measurement group_id="O4" value="0.17" spread="1.09"/>
                    <measurement group_id="O5" value="0.00" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="1.24"/>
                    <measurement group_id="O2" value="-0.15" spread="1.33"/>
                    <measurement group_id="O3" value="-0.45" spread="1.37"/>
                    <measurement group_id="O4" value="0.07" spread="1.10"/>
                    <measurement group_id="O5" value="-0.08" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="1.15"/>
                    <measurement group_id="O2" value="-0.08" spread="1.02"/>
                    <measurement group_id="O3" value="-0.28" spread="1.30"/>
                    <measurement group_id="O4" value="0.17" spread="1.32"/>
                    <measurement group_id="O5" value="0.03" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="1.08"/>
                    <measurement group_id="O2" value="0.00" spread="1.37"/>
                    <measurement group_id="O3" value="-0.64" spread="1.18"/>
                    <measurement group_id="O4" value="0.10" spread="1.07"/>
                    <measurement group_id="O5" value="-0.11" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="1.22"/>
                    <measurement group_id="O2" value="-0.05" spread="1.05"/>
                    <measurement group_id="O3" value="-0.51" spread="1.18"/>
                    <measurement group_id="O4" value="0.10" spread="1.10"/>
                    <measurement group_id="O5" value="0.13" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="1.10"/>
                    <measurement group_id="O2" value="0.08" spread="1.20"/>
                    <measurement group_id="O3" value="-0.62" spread="1.45"/>
                    <measurement group_id="O4" value="0.25" spread="1.19"/>
                    <measurement group_id="O5" value="0.13" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="1.25"/>
                    <measurement group_id="O2" value="-0.14" spread="1.29"/>
                    <measurement group_id="O3" value="-0.51" spread="1.00"/>
                    <measurement group_id="O4" value="0.20" spread="1.16"/>
                    <measurement group_id="O5" value="0.03" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="1.19"/>
                    <measurement group_id="O2" value="0.11" spread="1.09"/>
                    <measurement group_id="O3" value="-0.41" spread="1.04"/>
                    <measurement group_id="O4" value="0.38" spread="1.17"/>
                    <measurement group_id="O5" value="0.00" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 27</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="1.06"/>
                    <measurement group_id="O2" value="0.11" spread="0.97"/>
                    <measurement group_id="O3" value="-0.67" spread="1.14"/>
                    <measurement group_id="O4" value="0.00" spread="1.28"/>
                    <measurement group_id="O5" value="0.26" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="1.17"/>
                    <measurement group_id="O2" value="0.19" spread="1.05"/>
                    <measurement group_id="O3" value="-0.71" spread="1.20"/>
                    <measurement group_id="O4" value="0.10" spread="1.26"/>
                    <measurement group_id="O5" value="0.03" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="1.23"/>
                    <measurement group_id="O2" value="-0.08" spread="1.06"/>
                    <measurement group_id="O3" value="-0.56" spread="1.12"/>
                    <measurement group_id="O4" value="0.30" spread="1.36"/>
                    <measurement group_id="O5" value="-0.05" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="1.06"/>
                    <measurement group_id="O2" value="0.08" spread="1.23"/>
                    <measurement group_id="O3" value="-0.32" spread="1.19"/>
                    <measurement group_id="O4" value="0.10" spread="1.52"/>
                    <measurement group_id="O5" value="-0.03" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="1.30"/>
                    <measurement group_id="O2" value="-0.08" spread="1.16"/>
                    <measurement group_id="O3" value="-0.37" spread="0.99"/>
                    <measurement group_id="O4" value="0.23" spread="1.54"/>
                    <measurement group_id="O5" value="-0.05" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="1.19"/>
                    <measurement group_id="O2" value="-0.24" spread="1.04"/>
                    <measurement group_id="O3" value="-0.68" spread="1.21"/>
                    <measurement group_id="O4" value="0.30" spread="1.40"/>
                    <measurement group_id="O5" value="-0.10" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="1.30"/>
                    <measurement group_id="O2" value="0.00" spread="1.31"/>
                    <measurement group_id="O3" value="-0.56" spread="1.16"/>
                    <measurement group_id="O4" value="0.10" spread="1.37"/>
                    <measurement group_id="O5" value="-0.13" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="1.27"/>
                    <measurement group_id="O2" value="0.05" spread="1.08"/>
                    <measurement group_id="O3" value="-0.46" spread="1.14"/>
                    <measurement group_id="O4" value="0.25" spread="1.53"/>
                    <measurement group_id="O5" value="0.05" spread="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="1.43"/>
                    <measurement group_id="O2" value="0.14" spread="1.00"/>
                    <measurement group_id="O3" value="-0.54" spread="0.98"/>
                    <measurement group_id="O4" value="0.23" spread="1.29"/>
                    <measurement group_id="O5" value="-0.08" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="1.34"/>
                    <measurement group_id="O2" value="0.05" spread="1.18"/>
                    <measurement group_id="O3" value="-0.49" spread="1.14"/>
                    <measurement group_id="O4" value="0.20" spread="1.11"/>
                    <measurement group_id="O5" value="0.03" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="1.19"/>
                    <measurement group_id="O2" value="-0.03" spread="0.91"/>
                    <measurement group_id="O3" value="-0.64" spread="1.10"/>
                    <measurement group_id="O4" value="0.13" spread="1.45"/>
                    <measurement group_id="O5" value="-0.18" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="1.34"/>
                    <measurement group_id="O2" value="0.05" spread="1.01"/>
                    <measurement group_id="O3" value="-0.56" spread="1.10"/>
                    <measurement group_id="O4" value="0.07" spread="1.47"/>
                    <measurement group_id="O5" value="0.02" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Vital Sign Parameter of Temperature Over Time</title>
        <description>Vital sign assessment of temperature was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Vital Sign Parameter of Temperature Over Time</title>
          <description>Vital sign assessment of temperature was done at Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose), Day 2 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 8 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 15 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 22 (pre-dose, 5 minutes, 30 minutes and 1 hour post-dose), Day 27, Day 28 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 8 hours, 12 hours and 24 hours post-dose) and Day 35. A window of plus or minus 5 minutes was allowed during the active treatment visit vital sign assessments. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1, Day 2, Day 8, Day 15, Day 22, Day 27, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Degree celcius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.12"/>
                    <measurement group_id="O2" value="-0.00" spread="0.14"/>
                    <measurement group_id="O3" value="0.01" spread="0.11"/>
                    <measurement group_id="O4" value="0.04" spread="0.13"/>
                    <measurement group_id="O5" value="0.01" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.21"/>
                    <measurement group_id="O2" value="-0.01" spread="0.12"/>
                    <measurement group_id="O3" value="-0.00" spread="0.13"/>
                    <measurement group_id="O4" value="0.04" spread="0.12"/>
                    <measurement group_id="O5" value="0.03" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.18"/>
                    <measurement group_id="O2" value="-0.00" spread="0.16"/>
                    <measurement group_id="O3" value="0.00" spread="0.13"/>
                    <measurement group_id="O4" value="0.04" spread="0.10"/>
                    <measurement group_id="O5" value="0.03" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.19"/>
                    <measurement group_id="O2" value="0.01" spread="0.20"/>
                    <measurement group_id="O3" value="0.02" spread="0.14"/>
                    <measurement group_id="O4" value="0.06" spread="0.15"/>
                    <measurement group_id="O5" value="0.05" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.20"/>
                    <measurement group_id="O2" value="-0.00" spread="0.18"/>
                    <measurement group_id="O3" value="-0.03" spread="0.14"/>
                    <measurement group_id="O4" value="0.06" spread="0.16"/>
                    <measurement group_id="O5" value="0.01" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.17"/>
                    <measurement group_id="O2" value="0.02" spread="0.18"/>
                    <measurement group_id="O3" value="0.02" spread="0.18"/>
                    <measurement group_id="O4" value="0.05" spread="0.15"/>
                    <measurement group_id="O5" value="0.03" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.23"/>
                    <measurement group_id="O2" value="0.03" spread="0.20"/>
                    <measurement group_id="O3" value="0.03" spread="0.14"/>
                    <measurement group_id="O4" value="0.05" spread="0.14"/>
                    <measurement group_id="O5" value="0.02" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.24"/>
                    <measurement group_id="O2" value="0.01" spread="0.17"/>
                    <measurement group_id="O3" value="0.03" spread="0.18"/>
                    <measurement group_id="O4" value="0.05" spread="0.15"/>
                    <measurement group_id="O5" value="0.06" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.16"/>
                    <measurement group_id="O2" value="-0.03" spread="0.23"/>
                    <measurement group_id="O3" value="0.01" spread="0.18"/>
                    <measurement group_id="O4" value="0.01" spread="0.19"/>
                    <measurement group_id="O5" value="0.00" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.15"/>
                    <measurement group_id="O2" value="-0.03" spread="0.23"/>
                    <measurement group_id="O3" value="0.02" spread="0.18"/>
                    <measurement group_id="O4" value="0.01" spread="0.19"/>
                    <measurement group_id="O5" value="0.01" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.18"/>
                    <measurement group_id="O2" value="-0.00" spread="0.18"/>
                    <measurement group_id="O3" value="0.01" spread="0.16"/>
                    <measurement group_id="O4" value="-0.03" spread="0.16"/>
                    <measurement group_id="O5" value="0.05" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.13"/>
                    <measurement group_id="O2" value="-0.00" spread="0.15"/>
                    <measurement group_id="O3" value="-0.01" spread="0.14"/>
                    <measurement group_id="O4" value="0.02" spread="0.17"/>
                    <measurement group_id="O5" value="0.06" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.11"/>
                    <measurement group_id="O2" value="-0.00" spread="0.16"/>
                    <measurement group_id="O3" value="-0.00" spread="0.16"/>
                    <measurement group_id="O4" value="0.03" spread="0.14"/>
                    <measurement group_id="O5" value="0.04" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.25"/>
                    <measurement group_id="O2" value="0.03" spread="0.17"/>
                    <measurement group_id="O3" value="0.00" spread="0.24"/>
                    <measurement group_id="O4" value="0.02" spread="0.18"/>
                    <measurement group_id="O5" value="-0.01" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.21"/>
                    <measurement group_id="O2" value="0.03" spread="0.18"/>
                    <measurement group_id="O3" value="0.01" spread="0.19"/>
                    <measurement group_id="O4" value="0.01" spread="0.17"/>
                    <measurement group_id="O5" value="0.03" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.20"/>
                    <measurement group_id="O2" value="0.00" spread="0.16"/>
                    <measurement group_id="O3" value="-0.03" spread="0.19"/>
                    <measurement group_id="O4" value="0.03" spread="0.17"/>
                    <measurement group_id="O5" value="0.04" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.14"/>
                    <measurement group_id="O2" value="0.01" spread="0.16"/>
                    <measurement group_id="O3" value="-0.02" spread="0.21"/>
                    <measurement group_id="O4" value="0.03" spread="0.20"/>
                    <measurement group_id="O5" value="0.03" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.24"/>
                    <measurement group_id="O2" value="0.00" spread="0.17"/>
                    <measurement group_id="O3" value="0.02" spread="0.19"/>
                    <measurement group_id="O4" value="0.06" spread="0.21"/>
                    <measurement group_id="O5" value="0.01" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.20"/>
                    <measurement group_id="O2" value="0.01" spread="0.18"/>
                    <measurement group_id="O3" value="0.01" spread="0.20"/>
                    <measurement group_id="O4" value="0.05" spread="0.17"/>
                    <measurement group_id="O5" value="0.02" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.20"/>
                    <measurement group_id="O2" value="-0.01" spread="0.20"/>
                    <measurement group_id="O3" value="-0.01" spread="0.18"/>
                    <measurement group_id="O4" value="0.05" spread="0.18"/>
                    <measurement group_id="O5" value="0.03" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.14"/>
                    <measurement group_id="O2" value="0.04" spread="0.15"/>
                    <measurement group_id="O3" value="-0.02" spread="0.19"/>
                    <measurement group_id="O4" value="0.04" spread="0.15"/>
                    <measurement group_id="O5" value="0.01" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.20"/>
                    <measurement group_id="O2" value="0.04" spread="0.25"/>
                    <measurement group_id="O3" value="-0.02" spread="0.13"/>
                    <measurement group_id="O4" value="-0.01" spread="0.25"/>
                    <measurement group_id="O5" value="0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 5 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.17"/>
                    <measurement group_id="O2" value="0.04" spread="0.23"/>
                    <measurement group_id="O3" value="-0.00" spread="0.16"/>
                    <measurement group_id="O4" value="-0.01" spread="0.20"/>
                    <measurement group_id="O5" value="0.00" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.16"/>
                    <measurement group_id="O2" value="0.04" spread="0.21"/>
                    <measurement group_id="O3" value="-0.03" spread="0.12"/>
                    <measurement group_id="O4" value="0.03" spread="0.23"/>
                    <measurement group_id="O5" value="0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.17"/>
                    <measurement group_id="O2" value="0.05" spread="0.21"/>
                    <measurement group_id="O3" value="0.01" spread="0.14"/>
                    <measurement group_id="O4" value="0.02" spread="0.22"/>
                    <measurement group_id="O5" value="0.01" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 27</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.21"/>
                    <measurement group_id="O2" value="0.01" spread="0.24"/>
                    <measurement group_id="O3" value="0.01" spread="0.20"/>
                    <measurement group_id="O4" value="0.05" spread="0.21"/>
                    <measurement group_id="O5" value="0.03" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.17"/>
                    <measurement group_id="O2" value="-0.00" spread="0.18"/>
                    <measurement group_id="O3" value="-0.01" spread="0.19"/>
                    <measurement group_id="O4" value="0.00" spread="0.19"/>
                    <measurement group_id="O5" value="-0.01" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 15 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.17"/>
                    <measurement group_id="O2" value="-0.00" spread="0.20"/>
                    <measurement group_id="O3" value="0.00" spread="0.18"/>
                    <measurement group_id="O4" value="0.04" spread="0.21"/>
                    <measurement group_id="O5" value="-0.00" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.15"/>
                    <measurement group_id="O2" value="-0.01" spread="0.24"/>
                    <measurement group_id="O3" value="-0.01" spread="0.17"/>
                    <measurement group_id="O4" value="0.05" spread="0.24"/>
                    <measurement group_id="O5" value="0.02" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.17"/>
                    <measurement group_id="O2" value="-0.04" spread="0.28"/>
                    <measurement group_id="O3" value="-0.01" spread="0.15"/>
                    <measurement group_id="O4" value="0.04" spread="0.24"/>
                    <measurement group_id="O5" value="0.00" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.19"/>
                    <measurement group_id="O2" value="-0.00" spread="0.25"/>
                    <measurement group_id="O3" value="-0.04" spread="0.16"/>
                    <measurement group_id="O4" value="0.04" spread="0.18"/>
                    <measurement group_id="O5" value="0.02" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 3 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.13"/>
                    <measurement group_id="O2" value="0.01" spread="0.26"/>
                    <measurement group_id="O3" value="-0.01" spread="0.21"/>
                    <measurement group_id="O4" value="0.02" spread="0.22"/>
                    <measurement group_id="O5" value="0.00" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 4 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.25"/>
                    <measurement group_id="O2" value="0.00" spread="0.27"/>
                    <measurement group_id="O3" value="-0.02" spread="0.16"/>
                    <measurement group_id="O4" value="0.02" spread="0.22"/>
                    <measurement group_id="O5" value="0.01" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 8 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.21"/>
                    <measurement group_id="O2" value="0.05" spread="0.24"/>
                    <measurement group_id="O3" value="0.00" spread="0.17"/>
                    <measurement group_id="O4" value="0.05" spread="0.17"/>
                    <measurement group_id="O5" value="0.02" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 12 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.16"/>
                    <measurement group_id="O2" value="0.06" spread="0.27"/>
                    <measurement group_id="O3" value="0.01" spread="0.18"/>
                    <measurement group_id="O4" value="0.05" spread="0.21"/>
                    <measurement group_id="O5" value="-0.01" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, 24 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.22"/>
                    <measurement group_id="O2" value="-0.02" spread="0.25"/>
                    <measurement group_id="O3" value="-0.09" spread="0.35"/>
                    <measurement group_id="O4" value="0.02" spread="0.26"/>
                    <measurement group_id="O5" value="-0.02" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.24"/>
                    <measurement group_id="O2" value="0.07" spread="0.18"/>
                    <measurement group_id="O3" value="-0.02" spread="0.18"/>
                    <measurement group_id="O4" value="0.07" spread="0.23"/>
                    <measurement group_id="O5" value="0.02" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Electrocardiogram (ECG) Values Over Time</title>
        <description>12-lead ECG was obtained in the rested state. Participants lied in supine position with ECG leads on for at least 5 minutes prior to ECG recording. The ECG was performed at Day 1 (pre-dose and post-dose), Day 8, Day 15, Day 22, Day 28 (pre-dose and pre-dose) and Day 35, and included the assessment of PR interval, QRS interval, QT interval and QTc interval. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1 [post-dose], Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1, pre-dose) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Electrocardiogram (ECG) Values Over Time</title>
          <description>12-lead ECG was obtained in the rested state. Participants lied in supine position with ECG leads on for at least 5 minutes prior to ECG recording. The ECG was performed at Day 1 (pre-dose and post-dose), Day 8, Day 15, Day 22, Day 28 (pre-dose and pre-dose) and Day 35, and included the assessment of PR interval, QRS interval, QT interval and QTc interval. Baseline was defined as the assessment done on Day 1 (pre-dose). The change from Baseline was calculated by subtracting the Baseline value (Day 1, pre-dose) from the individual post-Baseline (Day 1 [post-dose], Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Millisecond</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PR interval, Day 1, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="9.92"/>
                    <measurement group_id="O2" value="1.47" spread="13.07"/>
                    <measurement group_id="O3" value="0.58" spread="12.43"/>
                    <measurement group_id="O4" value="0.32" spread="9.96"/>
                    <measurement group_id="O5" value="1.57" spread="11.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.26" spread="17.29"/>
                    <measurement group_id="O2" value="-3.42" spread="18.04"/>
                    <measurement group_id="O3" value="0.45" spread="14.15"/>
                    <measurement group_id="O4" value="-2.46" spread="14.66"/>
                    <measurement group_id="O5" value="-3.63" spread="15.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.79" spread="15.29"/>
                    <measurement group_id="O2" value="-3.20" spread="16.45"/>
                    <measurement group_id="O3" value="-5.10" spread="19.64"/>
                    <measurement group_id="O4" value="-0.78" spread="12.10"/>
                    <measurement group_id="O5" value="-1.03" spread="12.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.38" spread="16.84"/>
                    <measurement group_id="O2" value="-0.31" spread="18.12"/>
                    <measurement group_id="O3" value="-1.19" spread="14.86"/>
                    <measurement group_id="O4" value="0.15" spread="12.31"/>
                    <measurement group_id="O5" value="-1.46" spread="14.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.55" spread="14.81"/>
                    <measurement group_id="O2" value="-3.46" spread="18.59"/>
                    <measurement group_id="O3" value="-2.39" spread="14.43"/>
                    <measurement group_id="O4" value="3.70" spread="13.45"/>
                    <measurement group_id="O5" value="0.31" spread="17.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 28, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.98" spread="15.72"/>
                    <measurement group_id="O2" value="-1.22" spread="17.40"/>
                    <measurement group_id="O3" value="-1.59" spread="16.55"/>
                    <measurement group_id="O4" value="1.88" spread="15.35"/>
                    <measurement group_id="O5" value="3.33" spread="13.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PR interval, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="16.43"/>
                    <measurement group_id="O2" value="-1.22" spread="25.54"/>
                    <measurement group_id="O3" value="0.48" spread="19.88"/>
                    <measurement group_id="O4" value="1.95" spread="13.81"/>
                    <measurement group_id="O5" value="1.15" spread="10.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 1, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.83" spread="8.31"/>
                    <measurement group_id="O2" value="1.07" spread="9.67"/>
                    <measurement group_id="O3" value="-0.16" spread="3.31"/>
                    <measurement group_id="O4" value="0.54" spread="7.18"/>
                    <measurement group_id="O5" value="1.45" spread="8.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.50" spread="7.74"/>
                    <measurement group_id="O2" value="-17.49" spread="107.04"/>
                    <measurement group_id="O3" value="0.81" spread="6.78"/>
                    <measurement group_id="O4" value="0.56" spread="7.23"/>
                    <measurement group_id="O5" value="0.85" spread="10.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.05" spread="6.89"/>
                    <measurement group_id="O2" value="-16.15" spread="110.73"/>
                    <measurement group_id="O3" value="-0.17" spread="6.26"/>
                    <measurement group_id="O4" value="-1.37" spread="11.87"/>
                    <measurement group_id="O5" value="0.80" spread="8.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="5.88"/>
                    <measurement group_id="O2" value="-19.31" spread="112.93"/>
                    <measurement group_id="O3" value="-0.26" spread="7.15"/>
                    <measurement group_id="O4" value="-1.00" spread="5.43"/>
                    <measurement group_id="O5" value="0.28" spread="9.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.81" spread="9.55"/>
                    <measurement group_id="O2" value="-20.00" spread="120.11"/>
                    <measurement group_id="O3" value="-0.54" spread="6.24"/>
                    <measurement group_id="O4" value="-1.28" spread="6.80"/>
                    <measurement group_id="O5" value="-0.54" spread="7.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 28, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="11.71"/>
                    <measurement group_id="O2" value="-19.38" spread="120.28"/>
                    <measurement group_id="O3" value="-0.85" spread="7.62"/>
                    <measurement group_id="O4" value="-0.03" spread="6.62"/>
                    <measurement group_id="O5" value="0.21" spread="9.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QRS interval, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="6.55"/>
                    <measurement group_id="O2" value="-12.39" spread="112.59"/>
                    <measurement group_id="O3" value="-1.21" spread="5.58"/>
                    <measurement group_id="O4" value="-1.17" spread="10.59"/>
                    <measurement group_id="O5" value="0.83" spread="8.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 1, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.29" spread="14.09"/>
                    <measurement group_id="O2" value="-2.44" spread="20.72"/>
                    <measurement group_id="O3" value="1.23" spread="18.96"/>
                    <measurement group_id="O4" value="3.49" spread="18.44"/>
                    <measurement group_id="O5" value="1.17" spread="17.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.17" spread="18.65"/>
                    <measurement group_id="O2" value="-7.56" spread="32.44"/>
                    <measurement group_id="O3" value="-2.74" spread="21.35"/>
                    <measurement group_id="O4" value="0.68" spread="13.49"/>
                    <measurement group_id="O5" value="-2.98" spread="25.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="23.43"/>
                    <measurement group_id="O2" value="0.40" spread="21.66"/>
                    <measurement group_id="O3" value="-0.66" spread="22.63"/>
                    <measurement group_id="O4" value="-0.98" spread="15.75"/>
                    <measurement group_id="O5" value="1.53" spread="19.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="20.93"/>
                    <measurement group_id="O2" value="1.31" spread="21.31"/>
                    <measurement group_id="O3" value="1.36" spread="22.41"/>
                    <measurement group_id="O4" value="-6.00" spread="18.92"/>
                    <measurement group_id="O5" value="0.64" spread="18.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.17" spread="25.76"/>
                    <measurement group_id="O2" value="1.62" spread="19.05"/>
                    <measurement group_id="O3" value="1.46" spread="27.63"/>
                    <measurement group_id="O4" value="3.48" spread="20.88"/>
                    <measurement group_id="O5" value="1.00" spread="18.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 28, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="34.52"/>
                    <measurement group_id="O2" value="4.27" spread="18.31"/>
                    <measurement group_id="O3" value="3.80" spread="24.89"/>
                    <measurement group_id="O4" value="4.35" spread="24.70"/>
                    <measurement group_id="O5" value="-1.28" spread="24.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QT interval, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.10" spread="22.76"/>
                    <measurement group_id="O2" value="4.56" spread="22.44"/>
                    <measurement group_id="O3" value="0.36" spread="20.27"/>
                    <measurement group_id="O4" value="5.12" spread="26.01"/>
                    <measurement group_id="O5" value="4.27" spread="27.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 1, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.52" spread="16.05"/>
                    <measurement group_id="O2" value="-1.60" spread="16.31"/>
                    <measurement group_id="O3" value="1.28" spread="14.46"/>
                    <measurement group_id="O4" value="3.37" spread="18.91"/>
                    <measurement group_id="O5" value="-1.71" spread="23.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.02" spread="21.98"/>
                    <measurement group_id="O2" value="-3.40" spread="27.38"/>
                    <measurement group_id="O3" value="3.64" spread="20.77"/>
                    <measurement group_id="O4" value="4.17" spread="20.65"/>
                    <measurement group_id="O5" value="1.45" spread="25.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.57" spread="21.03"/>
                    <measurement group_id="O2" value="-3.05" spread="26.25"/>
                    <measurement group_id="O3" value="2.78" spread="15.96"/>
                    <measurement group_id="O4" value="0.68" spread="19.64"/>
                    <measurement group_id="O5" value="4.40" spread="23.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.21" spread="17.87"/>
                    <measurement group_id="O2" value="-4.21" spread="17.59"/>
                    <measurement group_id="O3" value="5.52" spread="17.55"/>
                    <measurement group_id="O4" value="-4.13" spread="23.18"/>
                    <measurement group_id="O5" value="-0.10" spread="22.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 28, pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.98" spread="17.02"/>
                    <measurement group_id="O2" value="2.35" spread="18.90"/>
                    <measurement group_id="O3" value="-0.71" spread="24.18"/>
                    <measurement group_id="O4" value="1.50" spread="19.86"/>
                    <measurement group_id="O5" value="-4.67" spread="19.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 28, post-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.05" spread="21.32"/>
                    <measurement group_id="O2" value="0.54" spread="21.20"/>
                    <measurement group_id="O3" value="2.39" spread="23.09"/>
                    <measurement group_id="O4" value="0.83" spread="19.86"/>
                    <measurement group_id="O5" value="-4.44" spread="20.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QTc interval, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.38" spread="19.88"/>
                    <measurement group_id="O2" value="-0.05" spread="21.78"/>
                    <measurement group_id="O3" value="2.90" spread="16.15"/>
                    <measurement group_id="O4" value="0.63" spread="26.55"/>
                    <measurement group_id="O5" value="-1.34" spread="28.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameters of Basophils, Eosinophils, Lymphocytes, Monocytes, Neutrophils, Platelet and White Blood Cell (WBC) Count Over Time</title>
        <description>Assessment for basophils, eosinophils, lymphocytes, monocytes, neutrophils, platelet and white blood cell (WBC) count were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameters of Basophils, Eosinophils, Lymphocytes, Monocytes, Neutrophils, Platelet and White Blood Cell (WBC) Count Over Time</title>
          <description>Assessment for basophils, eosinophils, lymphocytes, monocytes, neutrophils, platelet and white blood cell (WBC) count were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Giga cells per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseophil count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.02"/>
                    <measurement group_id="O2" value="0.00" spread="0.02"/>
                    <measurement group_id="O3" value="0.00" spread="0.01"/>
                    <measurement group_id="O4" value="0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseophil count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.02"/>
                    <measurement group_id="O2" value="0.01" spread="0.03"/>
                    <measurement group_id="O3" value="0.01" spread="0.03"/>
                    <measurement group_id="O4" value="-0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseophil count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.01"/>
                    <measurement group_id="O2" value="0.01" spread="0.03"/>
                    <measurement group_id="O3" value="-0.00" spread="0.02"/>
                    <measurement group_id="O4" value="-0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.01" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseophil count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.02"/>
                    <measurement group_id="O2" value="0.00" spread="0.02"/>
                    <measurement group_id="O3" value="0.00" spread="0.02"/>
                    <measurement group_id="O4" value="-0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseophil count Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.02"/>
                    <measurement group_id="O2" value="0.01" spread="0.02"/>
                    <measurement group_id="O3" value="0.00" spread="0.02"/>
                    <measurement group_id="O4" value="0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophil count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.14"/>
                    <measurement group_id="O2" value="0.01" spread="0.13"/>
                    <measurement group_id="O3" value="0.03" spread="0.17"/>
                    <measurement group_id="O4" value="-0.01" spread="0.09"/>
                    <measurement group_id="O5" value="0.01" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophil count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.13"/>
                    <measurement group_id="O2" value="0.01" spread="0.12"/>
                    <measurement group_id="O3" value="0.04" spread="0.28"/>
                    <measurement group_id="O4" value="0.01" spread="0.11"/>
                    <measurement group_id="O5" value="-0.03" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophil count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.21"/>
                    <measurement group_id="O2" value="0.01" spread="0.10"/>
                    <measurement group_id="O3" value="0.01" spread="0.15"/>
                    <measurement group_id="O4" value="0.02" spread="0.20"/>
                    <measurement group_id="O5" value="0.03" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophil count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.11"/>
                    <measurement group_id="O2" value="0.02" spread="0.13"/>
                    <measurement group_id="O3" value="0.02" spread="0.27"/>
                    <measurement group_id="O4" value="-0.00" spread="0.10"/>
                    <measurement group_id="O5" value="0.02" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophil count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.15"/>
                    <measurement group_id="O2" value="-0.01" spread="0.14"/>
                    <measurement group_id="O3" value="0.03" spread="0.24"/>
                    <measurement group_id="O4" value="-0.02" spread="0.11"/>
                    <measurement group_id="O5" value="0.05" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocyte count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.44"/>
                    <measurement group_id="O2" value="0.20" spread="0.59"/>
                    <measurement group_id="O3" value="0.10" spread="0.46"/>
                    <measurement group_id="O4" value="0.12" spread="0.53"/>
                    <measurement group_id="O5" value="0.20" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocyte count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.52"/>
                    <measurement group_id="O2" value="0.10" spread="0.58"/>
                    <measurement group_id="O3" value="0.16" spread="0.41"/>
                    <measurement group_id="O4" value="0.11" spread="0.46"/>
                    <measurement group_id="O5" value="0.05" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocyte count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.46"/>
                    <measurement group_id="O2" value="0.17" spread="0.54"/>
                    <measurement group_id="O3" value="0.22" spread="0.43"/>
                    <measurement group_id="O4" value="-0.00" spread="0.43"/>
                    <measurement group_id="O5" value="0.04" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocyte count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.48"/>
                    <measurement group_id="O2" value="-0.03" spread="0.49"/>
                    <measurement group_id="O3" value="0.49" spread="0.47"/>
                    <measurement group_id="O4" value="-0.02" spread="0.47"/>
                    <measurement group_id="O5" value="-0.07" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocyte count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.45"/>
                    <measurement group_id="O2" value="0.15" spread="0.58"/>
                    <measurement group_id="O3" value="0.18" spread="0.43"/>
                    <measurement group_id="O4" value="0.06" spread="0.46"/>
                    <measurement group_id="O5" value="0.10" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocyte count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.11"/>
                    <measurement group_id="O2" value="0.02" spread="0.16"/>
                    <measurement group_id="O3" value="0.03" spread="0.13"/>
                    <measurement group_id="O4" value="0.04" spread="0.15"/>
                    <measurement group_id="O5" value="0.05" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocyte count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.12"/>
                    <measurement group_id="O2" value="0.02" spread="0.18"/>
                    <measurement group_id="O3" value="0.04" spread="0.12"/>
                    <measurement group_id="O4" value="0.04" spread="0.14"/>
                    <measurement group_id="O5" value="0.04" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocyte count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.13"/>
                    <measurement group_id="O2" value="0.05" spread="0.19"/>
                    <measurement group_id="O3" value="0.01" spread="0.13"/>
                    <measurement group_id="O4" value="0.00" spread="0.18"/>
                    <measurement group_id="O5" value="0.05" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocyte count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.11"/>
                    <measurement group_id="O2" value="-0.03" spread="0.15"/>
                    <measurement group_id="O3" value="-0.00" spread="0.13"/>
                    <measurement group_id="O4" value="-0.01" spread="0.11"/>
                    <measurement group_id="O5" value="0.00" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocyte count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.11"/>
                    <measurement group_id="O2" value="0.02" spread="0.15"/>
                    <measurement group_id="O3" value="0.00" spread="0.15"/>
                    <measurement group_id="O4" value="-0.01" spread="0.15"/>
                    <measurement group_id="O5" value="0.02" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophil count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="1.08"/>
                    <measurement group_id="O2" value="0.37" spread="1.29"/>
                    <measurement group_id="O3" value="0.11" spread="1.05"/>
                    <measurement group_id="O4" value="0.10" spread="1.23"/>
                    <measurement group_id="O5" value="0.03" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophil count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.83"/>
                    <measurement group_id="O2" value="0.55" spread="1.19"/>
                    <measurement group_id="O3" value="0.27" spread="0.88"/>
                    <measurement group_id="O4" value="0.31" spread="1.27"/>
                    <measurement group_id="O5" value="0.46" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophil count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.82"/>
                    <measurement group_id="O2" value="0.56" spread="1.31"/>
                    <measurement group_id="O3" value="0.31" spread="0.71"/>
                    <measurement group_id="O4" value="0.14" spread="1.38"/>
                    <measurement group_id="O5" value="0.20" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophil count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="35"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="1.34"/>
                    <measurement group_id="O2" value="0.35" spread="1.23"/>
                    <measurement group_id="O3" value="-0.18" spread="0.96"/>
                    <measurement group_id="O4" value="0.19" spread="1.21"/>
                    <measurement group_id="O5" value="0.26" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophil count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="1.27"/>
                    <measurement group_id="O2" value="0.29" spread="1.18"/>
                    <measurement group_id="O3" value="0.09" spread="0.63"/>
                    <measurement group_id="O4" value="0.28" spread="1.13"/>
                    <measurement group_id="O5" value="0.55" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.37" spread="35.76"/>
                    <measurement group_id="O2" value="4.03" spread="40.19"/>
                    <measurement group_id="O3" value="2.34" spread="26.94"/>
                    <measurement group_id="O4" value="12.14" spread="28.82"/>
                    <measurement group_id="O5" value="5.75" spread="23.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.19" spread="41.90"/>
                    <measurement group_id="O2" value="13.45" spread="39.23"/>
                    <measurement group_id="O3" value="13.10" spread="28.86"/>
                    <measurement group_id="O4" value="15.40" spread="30.99"/>
                    <measurement group_id="O5" value="7.73" spread="28.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.28" spread="33.79"/>
                    <measurement group_id="O2" value="9.49" spread="42.29"/>
                    <measurement group_id="O3" value="16.42" spread="27.73"/>
                    <measurement group_id="O4" value="19.70" spread="29.51"/>
                    <measurement group_id="O5" value="4.49" spread="30.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.05" spread="33.65"/>
                    <measurement group_id="O2" value="3.81" spread="45.00"/>
                    <measurement group_id="O3" value="7.11" spread="21.05"/>
                    <measurement group_id="O4" value="5.22" spread="34.65"/>
                    <measurement group_id="O5" value="8.73" spread="43.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.89" spread="31.69"/>
                    <measurement group_id="O2" value="6.27" spread="42.88"/>
                    <measurement group_id="O3" value="11.58" spread="26.85"/>
                    <measurement group_id="O4" value="20.65" spread="35.89"/>
                    <measurement group_id="O5" value="15.75" spread="37.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WBC count, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="1.36"/>
                    <measurement group_id="O2" value="0.43" spread="1.66"/>
                    <measurement group_id="O3" value="0.37" spread="1.27"/>
                    <measurement group_id="O4" value="0.09" spread="1.45"/>
                    <measurement group_id="O5" value="0.22" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WBC count, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.94"/>
                    <measurement group_id="O2" value="0.67" spread="1.36"/>
                    <measurement group_id="O3" value="0.59" spread="1.10"/>
                    <measurement group_id="O4" value="0.44" spread="1.33"/>
                    <measurement group_id="O5" value="0.49" spread="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WBC count, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.92"/>
                    <measurement group_id="O2" value="0.75" spread="1.64"/>
                    <measurement group_id="O3" value="0.58" spread="0.94"/>
                    <measurement group_id="O4" value="0.18" spread="1.62"/>
                    <measurement group_id="O5" value="0.31" spread="1.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WBC count, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="1.43"/>
                    <measurement group_id="O2" value="0.21" spread="1.56"/>
                    <measurement group_id="O3" value="0.03" spread="1.20"/>
                    <measurement group_id="O4" value="0.02" spread="1.41"/>
                    <measurement group_id="O5" value="0.20" spread="1.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WBC count, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="1.29"/>
                    <measurement group_id="O2" value="0.29" spread="1.53"/>
                    <measurement group_id="O3" value="0.34" spread="0.90"/>
                    <measurement group_id="O4" value="0.26" spread="1.21"/>
                    <measurement group_id="O5" value="0.66" spread="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Red Blood Cell (RBC) Count Over Time</title>
        <description>Assessment for RBC count was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Red Blood Cell (RBC) Count Over Time</title>
          <description>Assessment for RBC count was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Trillion cells per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.19"/>
                    <measurement group_id="O2" value="0.03" spread="0.31"/>
                    <measurement group_id="O3" value="-0.02" spread="0.24"/>
                    <measurement group_id="O4" value="0.03" spread="0.23"/>
                    <measurement group_id="O5" value="0.03" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.19"/>
                    <measurement group_id="O2" value="0.02" spread="0.39"/>
                    <measurement group_id="O3" value="-0.04" spread="0.22"/>
                    <measurement group_id="O4" value="-0.03" spread="0.21"/>
                    <measurement group_id="O5" value="0.02" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.48"/>
                    <measurement group_id="O2" value="0.03" spread="0.36"/>
                    <measurement group_id="O3" value="-0.04" spread="0.22"/>
                    <measurement group_id="O4" value="-0.01" spread="0.27"/>
                    <measurement group_id="O5" value="-0.01" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.25"/>
                    <measurement group_id="O2" value="-0.10" spread="0.38"/>
                    <measurement group_id="O3" value="-0.11" spread="0.23"/>
                    <measurement group_id="O4" value="-0.09" spread="0.33"/>
                    <measurement group_id="O5" value="-0.12" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.27"/>
                    <measurement group_id="O2" value="-0.10" spread="0.35"/>
                    <measurement group_id="O3" value="-0.14" spread="0.21"/>
                    <measurement group_id="O4" value="-0.13" spread="0.41"/>
                    <measurement group_id="O5" value="-0.12" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Hematocrit Over Time</title>
        <description>Assessment for hematocrit was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Hematocrit Over Time</title>
          <description>Assessment for hematocrit was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.02"/>
                    <measurement group_id="O2" value="0.00" spread="0.03"/>
                    <measurement group_id="O3" value="-0.00" spread="0.03"/>
                    <measurement group_id="O4" value="0.00" spread="0.03"/>
                    <measurement group_id="O5" value="0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.02"/>
                    <measurement group_id="O2" value="0.00" spread="0.04"/>
                    <measurement group_id="O3" value="-0.00" spread="0.02"/>
                    <measurement group_id="O4" value="-0.00" spread="0.02"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.05"/>
                    <measurement group_id="O2" value="0.01" spread="0.03"/>
                    <measurement group_id="O3" value="-0.00" spread="0.02"/>
                    <measurement group_id="O4" value="-0.00" spread="0.03"/>
                    <measurement group_id="O5" value="-0.00" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.02"/>
                    <measurement group_id="O2" value="-0.01" spread="0.04"/>
                    <measurement group_id="O3" value="-0.01" spread="0.02"/>
                    <measurement group_id="O4" value="-0.01" spread="0.04"/>
                    <measurement group_id="O5" value="-0.01" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.03"/>
                    <measurement group_id="O2" value="-0.01" spread="0.03"/>
                    <measurement group_id="O3" value="-0.01" spread="0.02"/>
                    <measurement group_id="O4" value="-0.01" spread="0.03"/>
                    <measurement group_id="O5" value="-0.01" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Hemoglobin Over Time</title>
        <description>Assessment for hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Hemoglobin Over Time</title>
          <description>Assessment for hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Gram per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.75" spread="5.17"/>
                    <measurement group_id="O2" value="1.49" spread="9.28"/>
                    <measurement group_id="O3" value="-0.03" spread="7.36"/>
                    <measurement group_id="O4" value="0.47" spread="8.03"/>
                    <measurement group_id="O5" value="1.44" spread="6.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="5.13"/>
                    <measurement group_id="O2" value="1.09" spread="11.65"/>
                    <measurement group_id="O3" value="-0.32" spread="7.21"/>
                    <measurement group_id="O4" value="-0.81" spread="8.25"/>
                    <measurement group_id="O5" value="0.40" spread="6.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.08" spread="5.87"/>
                    <measurement group_id="O2" value="1.05" spread="10.71"/>
                    <measurement group_id="O3" value="-0.57" spread="7.56"/>
                    <measurement group_id="O4" value="-0.82" spread="9.70"/>
                    <measurement group_id="O5" value="-0.05" spread="5.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.43" spread="7.34"/>
                    <measurement group_id="O2" value="-2.60" spread="11.34"/>
                    <measurement group_id="O3" value="-2.32" spread="7.83"/>
                    <measurement group_id="O4" value="-2.58" spread="10.49"/>
                    <measurement group_id="O5" value="-3.83" spread="6.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.19" spread="8.37"/>
                    <measurement group_id="O2" value="-2.33" spread="11.10"/>
                    <measurement group_id="O3" value="-3.50" spread="7.53"/>
                    <measurement group_id="O4" value="-4.75" spread="9.87"/>
                    <measurement group_id="O5" value="-3.08" spread="6.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Over Time</title>
        <description>Assessment for mean corpuscular hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Over Time</title>
          <description>Assessment for mean corpuscular hemoglobin was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Picogram per cell</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.72"/>
                    <measurement group_id="O2" value="0.15" spread="0.79"/>
                    <measurement group_id="O3" value="0.23" spread="0.62"/>
                    <measurement group_id="O4" value="-0.16" spread="0.82"/>
                    <measurement group_id="O5" value="0.17" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.58"/>
                    <measurement group_id="O2" value="0.23" spread="1.14"/>
                    <measurement group_id="O3" value="0.27" spread="0.63"/>
                    <measurement group_id="O4" value="-0.03" spread="0.81"/>
                    <measurement group_id="O5" value="-0.08" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="1.79"/>
                    <measurement group_id="O2" value="0.14" spread="0.79"/>
                    <measurement group_id="O3" value="0.14" spread="0.65"/>
                    <measurement group_id="O4" value="-0.18" spread="0.90"/>
                    <measurement group_id="O5" value="0.10" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.74"/>
                    <measurement group_id="O2" value="0.11" spread="0.96"/>
                    <measurement group_id="O3" value="0.39" spread="0.67"/>
                    <measurement group_id="O4" value="0.03" spread="0.94"/>
                    <measurement group_id="O5" value="0.00" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.82"/>
                    <measurement group_id="O2" value="0.05" spread="1.36"/>
                    <measurement group_id="O3" value="0.38" spread="0.66"/>
                    <measurement group_id="O4" value="-0.11" spread="1.74"/>
                    <measurement group_id="O5" value="0.08" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Concentration Over Time</title>
        <description>Assessment for mean corpuscular hemoglobin concentration was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Hemoglobin Concentration Over Time</title>
          <description>Assessment for mean corpuscular hemoglobin concentration was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Gram hemoglobin per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.43" spread="8.10"/>
                    <measurement group_id="O2" value="0.00" spread="7.56"/>
                    <measurement group_id="O3" value="0.77" spread="8.39"/>
                    <measurement group_id="O4" value="0.56" spread="9.24"/>
                    <measurement group_id="O5" value="3.33" spread="9.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="7.36"/>
                    <measurement group_id="O2" value="0.31" spread="8.22"/>
                    <measurement group_id="O3" value="2.16" spread="7.50"/>
                    <measurement group_id="O4" value="-0.63" spread="11.34"/>
                    <measurement group_id="O5" value="0.31" spread="8.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.00" spread="21.58"/>
                    <measurement group_id="O2" value="-1.25" spread="8.33"/>
                    <measurement group_id="O3" value="0.25" spread="9.47"/>
                    <measurement group_id="O4" value="-2.29" spread="11.65"/>
                    <measurement group_id="O5" value="1.56" spread="7.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.56" spread="8.08"/>
                    <measurement group_id="O2" value="1.85" spread="8.34"/>
                    <measurement group_id="O3" value="1.47" spread="6.57"/>
                    <measurement group_id="O4" value="-0.59" spread="12.78"/>
                    <measurement group_id="O5" value="0.00" spread="8.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.35" spread="7.81"/>
                    <measurement group_id="O2" value="0.32" spread="11.69"/>
                    <measurement group_id="O3" value="-0.81" spread="7.22"/>
                    <measurement group_id="O4" value="0.32" spread="12.51"/>
                    <measurement group_id="O5" value="-1.54" spread="7.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Volume Over Time</title>
        <description>Assessment for mean corpuscular volume was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hematology Parameter of Mean Corpuscular Volume Over Time</title>
          <description>Assessment for mean corpuscular volume was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Femtoliter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="1.21"/>
                    <measurement group_id="O2" value="0.28" spread="1.77"/>
                    <measurement group_id="O3" value="0.18" spread="1.68"/>
                    <measurement group_id="O4" value="-0.33" spread="2.24"/>
                    <measurement group_id="O5" value="-0.17" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="1.29"/>
                    <measurement group_id="O2" value="0.69" spread="3.35"/>
                    <measurement group_id="O3" value="0.11" spread="1.54"/>
                    <measurement group_id="O4" value="-0.06" spread="2.71"/>
                    <measurement group_id="O5" value="-0.03" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="1.98"/>
                    <measurement group_id="O2" value="0.59" spread="1.70"/>
                    <measurement group_id="O3" value="0.05" spread="1.72"/>
                    <measurement group_id="O4" value="0.03" spread="2.27"/>
                    <measurement group_id="O5" value="0.13" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" spread="1.89"/>
                    <measurement group_id="O2" value="-0.19" spread="2.43"/>
                    <measurement group_id="O3" value="0.29" spread="1.17"/>
                    <measurement group_id="O4" value="0.29" spread="2.70"/>
                    <measurement group_id="O5" value="0.22" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="1.74"/>
                    <measurement group_id="O2" value="0.74" spread="3.01"/>
                    <measurement group_id="O3" value="0.73" spread="1.63"/>
                    <measurement group_id="O4" value="-0.71" spread="4.27"/>
                    <measurement group_id="O5" value="0.77" spread="1.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Coagulation Parameters of Activated Partial Thromplastin Time (aPTT) and Prothrombin Time (PT) Over Time</title>
        <description>Assessment for aPTT and PT were performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1), Day 28 and Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Coagulation Parameters of Activated Partial Thromplastin Time (aPTT) and Prothrombin Time (PT) Over Time</title>
          <description>Assessment for aPTT and PT were performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>aPTT, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="6.78"/>
                    <measurement group_id="O2" value="1.51" spread="9.88"/>
                    <measurement group_id="O3" value="-1.58" spread="6.98"/>
                    <measurement group_id="O4" value="1.41" spread="13.03"/>
                    <measurement group_id="O5" value="1.26" spread="10.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>aPTT, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="33"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.43" spread="6.99"/>
                    <measurement group_id="O2" value="-1.73" spread="4.28"/>
                    <measurement group_id="O3" value="-1.46" spread="4.31"/>
                    <measurement group_id="O4" value="-1.28" spread="4.33"/>
                    <measurement group_id="O5" value="-0.84" spread="5.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PT, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.28" spread="1.62"/>
                    <measurement group_id="O2" value="0.18" spread="2.68"/>
                    <measurement group_id="O3" value="0.20" spread="2.99"/>
                    <measurement group_id="O4" value="-0.18" spread="1.43"/>
                    <measurement group_id="O5" value="-0.36" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PT, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="33"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="1.62"/>
                    <measurement group_id="O2" value="-0.45" spread="1.13"/>
                    <measurement group_id="O3" value="-0.26" spread="0.83"/>
                    <measurement group_id="O4" value="-0.47" spread="2.07"/>
                    <measurement group_id="O5" value="-0.44" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Coagulation Parameter of International Normalized Ratio Over Time</title>
        <description>Assessment for international normalized ratio was performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1), Day 28 and Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Coagulation Parameter of International Normalized Ratio Over Time</title>
          <description>Assessment for international normalized ratio was performed on Day 1, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.13"/>
                    <measurement group_id="O2" value="0.02" spread="0.24"/>
                    <measurement group_id="O3" value="0.01" spread="0.24"/>
                    <measurement group_id="O4" value="-0.01" spread="0.11"/>
                    <measurement group_id="O5" value="-0.03" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="33"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.13"/>
                    <measurement group_id="O2" value="-0.03" spread="0.09"/>
                    <measurement group_id="O3" value="-0.02" spread="0.07"/>
                    <measurement group_id="O4" value="-0.04" spread="0.16"/>
                    <measurement group_id="O5" value="-0.04" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Chemistry Parameters of Alanine Aminotransferase (ALT), Aspartate Aminotrasferase (AST), Alkaline Phosphatase (ALP), Creatinine Phosphokinase and Lactate Dehydrogenase (LDH) Over Time</title>
        <description>Assessment for ALT, AST, ALP, creatinine phosphokinase and LDH were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Chemistry Parameters of Alanine Aminotransferase (ALT), Aspartate Aminotrasferase (AST), Alkaline Phosphatase (ALP), Creatinine Phosphokinase and Lactate Dehydrogenase (LDH) Over Time</title>
          <description>Assessment for ALT, AST, ALP, creatinine phosphokinase and LDH were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>International units per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ALT, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="8.33"/>
                    <measurement group_id="O2" value="-0.90" spread="6.99"/>
                    <measurement group_id="O3" value="1.18" spread="10.46"/>
                    <measurement group_id="O4" value="-1.53" spread="6.48"/>
                    <measurement group_id="O5" value="-0.46" spread="8.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="15.17"/>
                    <measurement group_id="O2" value="-0.54" spread="7.99"/>
                    <measurement group_id="O3" value="-0.21" spread="10.54"/>
                    <measurement group_id="O4" value="-2.69" spread="6.69"/>
                    <measurement group_id="O5" value="-1.95" spread="8.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="13.64"/>
                    <measurement group_id="O2" value="3.05" spread="13.37"/>
                    <measurement group_id="O3" value="-0.41" spread="10.98"/>
                    <measurement group_id="O4" value="-0.21" spread="9.78"/>
                    <measurement group_id="O5" value="-3.71" spread="11.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.79" spread="11.14"/>
                    <measurement group_id="O2" value="0.56" spread="13.18"/>
                    <measurement group_id="O3" value="-0.47" spread="13.17"/>
                    <measurement group_id="O4" value="-2.27" spread="9.81"/>
                    <measurement group_id="O5" value="-3.86" spread="11.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.49" spread="11.86"/>
                    <measurement group_id="O2" value="-0.38" spread="9.43"/>
                    <measurement group_id="O3" value="-0.97" spread="10.85"/>
                    <measurement group_id="O4" value="-3.06" spread="9.14"/>
                    <measurement group_id="O5" value="-3.13" spread="11.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.22" spread="7.60"/>
                    <measurement group_id="O2" value="-0.63" spread="9.80"/>
                    <measurement group_id="O3" value="-1.60" spread="8.15"/>
                    <measurement group_id="O4" value="-3.24" spread="9.00"/>
                    <measurement group_id="O5" value="0.63" spread="9.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.61" spread="15.02"/>
                    <measurement group_id="O2" value="-4.17" spread="14.55"/>
                    <measurement group_id="O3" value="-2.05" spread="12.83"/>
                    <measurement group_id="O4" value="-5.67" spread="18.08"/>
                    <measurement group_id="O5" value="-1.65" spread="10.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.17" spread="10.10"/>
                    <measurement group_id="O2" value="-0.55" spread="17.35"/>
                    <measurement group_id="O3" value="-0.22" spread="13.95"/>
                    <measurement group_id="O4" value="-2.08" spread="19.56"/>
                    <measurement group_id="O5" value="-2.20" spread="12.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.73" spread="12.20"/>
                    <measurement group_id="O2" value="-1.34" spread="19.89"/>
                    <measurement group_id="O3" value="-3.33" spread="14.41"/>
                    <measurement group_id="O4" value="-4.61" spread="18.06"/>
                    <measurement group_id="O5" value="-4.05" spread="15.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.95" spread="12.74"/>
                    <measurement group_id="O2" value="-2.10" spread="15.76"/>
                    <measurement group_id="O3" value="-2.71" spread="13.71"/>
                    <measurement group_id="O4" value="-6.34" spread="16.37"/>
                    <measurement group_id="O5" value="-4.69" spread="16.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.33" spread="10.28"/>
                    <measurement group_id="O2" value="-1.25" spread="6.30"/>
                    <measurement group_id="O3" value="-0.63" spread="6.92"/>
                    <measurement group_id="O4" value="-1.18" spread="10.44"/>
                    <measurement group_id="O5" value="0.46" spread="4.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.97" spread="13.71"/>
                    <measurement group_id="O2" value="-0.54" spread="6.27"/>
                    <measurement group_id="O3" value="-0.38" spread="9.60"/>
                    <measurement group_id="O4" value="-2.85" spread="11.39"/>
                    <measurement group_id="O5" value="0.37" spread="5.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.36" spread="11.82"/>
                    <measurement group_id="O2" value="1.47" spread="6.43"/>
                    <measurement group_id="O3" value="-0.95" spread="11.51"/>
                    <measurement group_id="O4" value="-0.97" spread="12.87"/>
                    <measurement group_id="O5" value="-1.50" spread="6.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.28" spread="11.28"/>
                    <measurement group_id="O2" value="-1.39" spread="6.93"/>
                    <measurement group_id="O3" value="-0.69" spread="9.92"/>
                    <measurement group_id="O4" value="-2.23" spread="11.76"/>
                    <measurement group_id="O5" value="-1.44" spread="4.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.14" spread="11.95"/>
                    <measurement group_id="O2" value="-1.38" spread="6.52"/>
                    <measurement group_id="O3" value="-0.82" spread="10.05"/>
                    <measurement group_id="O4" value="-1.88" spread="12.15"/>
                    <measurement group_id="O5" value="-1.88" spread="5.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine phosphokinase, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.05" spread="30.14"/>
                    <measurement group_id="O2" value="11.25" spread="79.26"/>
                    <measurement group_id="O3" value="-10.95" spread="84.04"/>
                    <measurement group_id="O4" value="-3.11" spread="30.12"/>
                    <measurement group_id="O5" value="-8.37" spread="100.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine phosphokinase, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.03" spread="39.62"/>
                    <measurement group_id="O2" value="4.46" spread="33.64"/>
                    <measurement group_id="O3" value="-10.23" spread="77.79"/>
                    <measurement group_id="O4" value="-7.06" spread="43.44"/>
                    <measurement group_id="O5" value="-0.05" spread="101.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine phosphokinase, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="33.55"/>
                    <measurement group_id="O2" value="27.54" spread="97.86"/>
                    <measurement group_id="O3" value="-19.40" spread="74.31"/>
                    <measurement group_id="O4" value="6.47" spread="33.44"/>
                    <measurement group_id="O5" value="-9.18" spread="100.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine phosphokinase, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.74" spread="51.30"/>
                    <measurement group_id="O2" value="2.61" spread="32.25"/>
                    <measurement group_id="O3" value="-15.03" spread="84.44"/>
                    <measurement group_id="O4" value="12.65" spread="40.68"/>
                    <measurement group_id="O5" value="-3.47" spread="110.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine phosphokinase, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.65" spread="23.19"/>
                    <measurement group_id="O2" value="0.38" spread="31.87"/>
                    <measurement group_id="O3" value="-12.58" spread="82.07"/>
                    <measurement group_id="O4" value="8.30" spread="33.05"/>
                    <measurement group_id="O5" value="-4.33" spread="104.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDH, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.27" spread="55.02"/>
                    <measurement group_id="O2" value="0.03" spread="20.69"/>
                    <measurement group_id="O3" value="1.51" spread="20.44"/>
                    <measurement group_id="O4" value="-5.23" spread="18.38"/>
                    <measurement group_id="O5" value="-0.54" spread="14.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDH, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.31" spread="52.15"/>
                    <measurement group_id="O2" value="0.58" spread="20.51"/>
                    <measurement group_id="O3" value="-2.45" spread="23.63"/>
                    <measurement group_id="O4" value="-6.09" spread="29.60"/>
                    <measurement group_id="O5" value="-2.64" spread="16.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDH, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="30"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.84" spread="58.19"/>
                    <measurement group_id="O2" value="-0.33" spread="21.26"/>
                    <measurement group_id="O3" value="-2.34" spread="22.19"/>
                    <measurement group_id="O4" value="-3.61" spread="22.03"/>
                    <measurement group_id="O5" value="-3.42" spread="16.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDH, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="32"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.27" spread="56.13"/>
                    <measurement group_id="O2" value="-5.04" spread="19.71"/>
                    <measurement group_id="O3" value="-7.44" spread="18.31"/>
                    <measurement group_id="O4" value="-6.70" spread="16.99"/>
                    <measurement group_id="O5" value="-1.48" spread="16.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDH, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.47" spread="60.72"/>
                    <measurement group_id="O2" value="-1.74" spread="20.90"/>
                    <measurement group_id="O3" value="2.19" spread="25.99"/>
                    <measurement group_id="O4" value="-1.65" spread="23.37"/>
                    <measurement group_id="O5" value="-3.68" spread="16.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Chemistry Parameter of Bicarbonate, Blood Urea Nitrogen (BUN), Calcium, Chloride, Magnesium, Phosphate, Potassium and Sodium Over Time</title>
        <description>Assessment for bicarbonate, BUN, calcium, chloride, magnesium, phosphate, potassium and sodium were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Chemistry Parameter of Bicarbonate, Blood Urea Nitrogen (BUN), Calcium, Chloride, Magnesium, Phosphate, Potassium and Sodium Over Time</title>
          <description>Assessment for bicarbonate, BUN, calcium, chloride, magnesium, phosphate, potassium and sodium were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Micromole (mmol) per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Bicarbonate, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="2.69"/>
                    <measurement group_id="O2" value="0.78" spread="3.01"/>
                    <measurement group_id="O3" value="0.62" spread="2.40"/>
                    <measurement group_id="O4" value="0.13" spread="2.48"/>
                    <measurement group_id="O5" value="-0.17" spread="2.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="2.36"/>
                    <measurement group_id="O2" value="1.47" spread="2.68"/>
                    <measurement group_id="O3" value="0.41" spread="2.45"/>
                    <measurement group_id="O4" value="0.42" spread="2.52"/>
                    <measurement group_id="O5" value="0.03" spread="2.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="2.71"/>
                    <measurement group_id="O2" value="1.45" spread="2.69"/>
                    <measurement group_id="O3" value="0.90" spread="2.96"/>
                    <measurement group_id="O4" value="0.03" spread="2.49"/>
                    <measurement group_id="O5" value="0.00" spread="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="2.61"/>
                    <measurement group_id="O2" value="0.40" spread="2.66"/>
                    <measurement group_id="O3" value="-0.37" spread="2.67"/>
                    <measurement group_id="O4" value="-0.13" spread="2.42"/>
                    <measurement group_id="O5" value="-0.68" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="2.96"/>
                    <measurement group_id="O2" value="0.51" spread="2.61"/>
                    <measurement group_id="O3" value="0.60" spread="2.65"/>
                    <measurement group_id="O4" value="-0.14" spread="2.31"/>
                    <measurement group_id="O5" value="-0.48" spread="2.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="1.40"/>
                    <measurement group_id="O2" value="0.30" spread="2.05"/>
                    <measurement group_id="O3" value="0.29" spread="1.39"/>
                    <measurement group_id="O4" value="0.15" spread="1.40"/>
                    <measurement group_id="O5" value="0.03" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="1.43"/>
                    <measurement group_id="O2" value="0.16" spread="2.19"/>
                    <measurement group_id="O3" value="0.15" spread="1.00"/>
                    <measurement group_id="O4" value="0.42" spread="1.33"/>
                    <measurement group_id="O5" value="0.36" spread="1.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="1.21"/>
                    <measurement group_id="O2" value="0.36" spread="2.01"/>
                    <measurement group_id="O3" value="0.27" spread="1.16"/>
                    <measurement group_id="O4" value="0.01" spread="1.46"/>
                    <measurement group_id="O5" value="0.16" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="1.39"/>
                    <measurement group_id="O2" value="0.91" spread="2.11"/>
                    <measurement group_id="O3" value="0.24" spread="1.29"/>
                    <measurement group_id="O4" value="-0.15" spread="1.49"/>
                    <measurement group_id="O5" value="0.09" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="1.51"/>
                    <measurement group_id="O2" value="0.35" spread="1.78"/>
                    <measurement group_id="O3" value="0.22" spread="1.40"/>
                    <measurement group_id="O4" value="-0.57" spread="1.37"/>
                    <measurement group_id="O5" value="-0.11" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.09"/>
                    <measurement group_id="O2" value="0.02" spread="0.12"/>
                    <measurement group_id="O3" value="0.03" spread="0.11"/>
                    <measurement group_id="O4" value="0.05" spread="0.10"/>
                    <measurement group_id="O5" value="0.02" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.10"/>
                    <measurement group_id="O2" value="0.00" spread="0.15"/>
                    <measurement group_id="O3" value="0.01" spread="0.10"/>
                    <measurement group_id="O4" value="0.05" spread="0.12"/>
                    <measurement group_id="O5" value="-0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.08"/>
                    <measurement group_id="O2" value="0.01" spread="0.13"/>
                    <measurement group_id="O3" value="0.01" spread="0.10"/>
                    <measurement group_id="O4" value="0.05" spread="0.08"/>
                    <measurement group_id="O5" value="-0.00" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.11"/>
                    <measurement group_id="O2" value="-0.02" spread="0.15"/>
                    <measurement group_id="O3" value="-0.03" spread="0.12"/>
                    <measurement group_id="O4" value="0.02" spread="0.11"/>
                    <measurement group_id="O5" value="-0.04" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.11"/>
                    <measurement group_id="O2" value="-0.01" spread="0.11"/>
                    <measurement group_id="O3" value="-0.00" spread="0.09"/>
                    <measurement group_id="O4" value="0.02" spread="0.08"/>
                    <measurement group_id="O5" value="-0.02" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" spread="2.44"/>
                    <measurement group_id="O2" value="-0.14" spread="3.07"/>
                    <measurement group_id="O3" value="0.46" spread="2.96"/>
                    <measurement group_id="O4" value="0.12" spread="2.82"/>
                    <measurement group_id="O5" value="-0.80" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="3.01"/>
                    <measurement group_id="O2" value="0.00" spread="3.16"/>
                    <measurement group_id="O3" value="0.29" spread="2.63"/>
                    <measurement group_id="O4" value="0.90" spread="2.50"/>
                    <measurement group_id="O5" value="-0.71" spread="3.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" spread="2.61"/>
                    <measurement group_id="O2" value="-0.26" spread="3.27"/>
                    <measurement group_id="O3" value="0.45" spread="2.98"/>
                    <measurement group_id="O4" value="1.10" spread="3.11"/>
                    <measurement group_id="O5" value="-0.65" spread="3.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="2.78"/>
                    <measurement group_id="O2" value="0.17" spread="3.30"/>
                    <measurement group_id="O3" value="0.54" spread="3.06"/>
                    <measurement group_id="O4" value="0.43" spread="3.27"/>
                    <measurement group_id="O5" value="0.00" spread="3.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" spread="3.00"/>
                    <measurement group_id="O2" value="0.98" spread="2.88"/>
                    <measurement group_id="O3" value="1.40" spread="3.00"/>
                    <measurement group_id="O4" value="1.38" spread="3.13"/>
                    <measurement group_id="O5" value="0.95" spread="3.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.07"/>
                    <measurement group_id="O2" value="0.00" spread="0.06"/>
                    <measurement group_id="O3" value="-0.02" spread="0.06"/>
                    <measurement group_id="O4" value="-0.01" spread="0.06"/>
                    <measurement group_id="O5" value="0.01" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.06"/>
                    <measurement group_id="O2" value="-0.01" spread="0.07"/>
                    <measurement group_id="O3" value="-0.01" spread="0.06"/>
                    <measurement group_id="O4" value="-0.01" spread="0.06"/>
                    <measurement group_id="O5" value="-0.00" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.08"/>
                    <measurement group_id="O2" value="0.00" spread="0.07"/>
                    <measurement group_id="O3" value="-0.01" spread="0.06"/>
                    <measurement group_id="O4" value="0.00" spread="0.06"/>
                    <measurement group_id="O5" value="-0.00" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.06"/>
                    <measurement group_id="O2" value="-0.01" spread="0.06"/>
                    <measurement group_id="O3" value="-0.02" spread="0.06"/>
                    <measurement group_id="O4" value="0.01" spread="0.06"/>
                    <measurement group_id="O5" value="-0.01" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.06"/>
                    <measurement group_id="O2" value="-0.02" spread="0.08"/>
                    <measurement group_id="O3" value="-0.01" spread="0.06"/>
                    <measurement group_id="O4" value="-0.00" spread="0.08"/>
                    <measurement group_id="O5" value="-0.00" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.21"/>
                    <measurement group_id="O2" value="-0.02" spread="0.19"/>
                    <measurement group_id="O3" value="-0.00" spread="0.18"/>
                    <measurement group_id="O4" value="-0.03" spread="0.20"/>
                    <measurement group_id="O5" value="0.03" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.21"/>
                    <measurement group_id="O2" value="-0.01" spread="0.16"/>
                    <measurement group_id="O3" value="-0.01" spread="0.15"/>
                    <measurement group_id="O4" value="-0.04" spread="0.20"/>
                    <measurement group_id="O5" value="-0.01" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.21"/>
                    <measurement group_id="O2" value="0.04" spread="0.19"/>
                    <measurement group_id="O3" value="-0.01" spread="0.16"/>
                    <measurement group_id="O4" value="-0.03" spread="0.22"/>
                    <measurement group_id="O5" value="-0.00" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.20"/>
                    <measurement group_id="O2" value="-0.00" spread="0.19"/>
                    <measurement group_id="O3" value="0.02" spread="0.18"/>
                    <measurement group_id="O4" value="-0.03" spread="0.22"/>
                    <measurement group_id="O5" value="-0.00" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.20"/>
                    <measurement group_id="O2" value="-0.04" spread="0.18"/>
                    <measurement group_id="O3" value="-0.01" spread="0.14"/>
                    <measurement group_id="O4" value="-0.02" spread="0.23"/>
                    <measurement group_id="O5" value="0.04" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.48"/>
                    <measurement group_id="O2" value="0.11" spread="0.38"/>
                    <measurement group_id="O3" value="0.27" spread="0.45"/>
                    <measurement group_id="O4" value="0.24" spread="0.47"/>
                    <measurement group_id="O5" value="0.19" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.46"/>
                    <measurement group_id="O2" value="0.16" spread="0.35"/>
                    <measurement group_id="O3" value="0.25" spread="0.41"/>
                    <measurement group_id="O4" value="0.34" spread="0.47"/>
                    <measurement group_id="O5" value="0.13" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.53"/>
                    <measurement group_id="O2" value="0.13" spread="0.40"/>
                    <measurement group_id="O3" value="0.28" spread="0.41"/>
                    <measurement group_id="O4" value="0.31" spread="0.51"/>
                    <measurement group_id="O5" value="0.14" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.43"/>
                    <measurement group_id="O2" value="-0.02" spread="0.52"/>
                    <measurement group_id="O3" value="0.07" spread="0.37"/>
                    <measurement group_id="O4" value="0.03" spread="0.48"/>
                    <measurement group_id="O5" value="-0.20" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.59"/>
                    <measurement group_id="O2" value="0.07" spread="0.45"/>
                    <measurement group_id="O3" value="0.23" spread="0.35"/>
                    <measurement group_id="O4" value="0.20" spread="0.44"/>
                    <measurement group_id="O5" value="0.10" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="2.48"/>
                    <measurement group_id="O2" value="-0.33" spread="2.72"/>
                    <measurement group_id="O3" value="0.29" spread="2.62"/>
                    <measurement group_id="O4" value="0.05" spread="2.93"/>
                    <measurement group_id="O5" value="-0.41" spread="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="3.08"/>
                    <measurement group_id="O2" value="-0.53" spread="2.69"/>
                    <measurement group_id="O3" value="-0.31" spread="2.57"/>
                    <measurement group_id="O4" value="0.80" spread="2.90"/>
                    <measurement group_id="O5" value="-0.59" spread="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="2.42"/>
                    <measurement group_id="O2" value="-0.46" spread="2.34"/>
                    <measurement group_id="O3" value="0.29" spread="2.80"/>
                    <measurement group_id="O4" value="1.03" spread="3.06"/>
                    <measurement group_id="O5" value="-0.63" spread="2.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="2.87"/>
                    <measurement group_id="O2" value="-0.11" spread="3.35"/>
                    <measurement group_id="O3" value="-0.15" spread="2.82"/>
                    <measurement group_id="O4" value="0.73" spread="2.67"/>
                    <measurement group_id="O5" value="-0.40" spread="3.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="2.94"/>
                    <measurement group_id="O2" value="0.07" spread="2.78"/>
                    <measurement group_id="O3" value="0.57" spread="3.01"/>
                    <measurement group_id="O4" value="1.10" spread="2.33"/>
                    <measurement group_id="O5" value="0.24" spread="2.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Chemistry Parameter of Direct Bilirubin, Indirect Bilirubin, Serum Creatinine, Total Bilirubin and Uric Acid Over Time</title>
        <description>Assessment for direct bilirubin, indirect bilirubin, serum creatinine, total bilirubin and uric acid were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Chemistry Parameter of Direct Bilirubin, Indirect Bilirubin, Serum Creatinine, Total Bilirubin and Uric Acid Over Time</title>
          <description>Assessment for direct bilirubin, indirect bilirubin, serum creatinine, total bilirubin and uric acid were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Micromole per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Direct bilirubin, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.88"/>
                    <measurement group_id="O2" value="0.26" spread="0.78"/>
                    <measurement group_id="O3" value="0.27" spread="0.65"/>
                    <measurement group_id="O4" value="0.13" spread="0.55"/>
                    <measurement group_id="O5" value="0.30" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.68"/>
                    <measurement group_id="O2" value="0.19" spread="0.60"/>
                    <measurement group_id="O3" value="0.13" spread="0.52"/>
                    <measurement group_id="O4" value="-0.06" spread="0.44"/>
                    <measurement group_id="O5" value="0.43" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.70"/>
                    <measurement group_id="O2" value="0.10" spread="0.70"/>
                    <measurement group_id="O3" value="0.08" spread="0.35"/>
                    <measurement group_id="O4" value="0.03" spread="0.74"/>
                    <measurement group_id="O5" value="0.21" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="32"/>
                    <count group_id="O4" value="28"/>
                    <count group_id="O5" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.59"/>
                    <measurement group_id="O2" value="0.07" spread="0.38"/>
                    <measurement group_id="O3" value="0.19" spread="0.74"/>
                    <measurement group_id="O4" value="-0.11" spread="0.50"/>
                    <measurement group_id="O5" value="0.26" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.92"/>
                    <measurement group_id="O2" value="-0.06" spread="0.60"/>
                    <measurement group_id="O3" value="-0.05" spread="0.32"/>
                    <measurement group_id="O4" value="-0.25" spread="0.67"/>
                    <measurement group_id="O5" value="0.00" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indirect bilirubin, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="3.02"/>
                    <measurement group_id="O2" value="1.06" spread="3.31"/>
                    <measurement group_id="O3" value="1.49" spread="3.52"/>
                    <measurement group_id="O4" value="0.91" spread="3.32"/>
                    <measurement group_id="O5" value="1.22" spread="4.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indirect bilirubin, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="2.47"/>
                    <measurement group_id="O2" value="0.71" spread="4.03"/>
                    <measurement group_id="O3" value="0.56" spread="2.55"/>
                    <measurement group_id="O4" value="0.52" spread="3.37"/>
                    <measurement group_id="O5" value="1.22" spread="2.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indirect bilirubin, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.70" spread="3.44"/>
                    <measurement group_id="O2" value="0.61" spread="3.04"/>
                    <measurement group_id="O3" value="0.62" spread="3.27"/>
                    <measurement group_id="O4" value="1.09" spread="3.37"/>
                    <measurement group_id="O5" value="0.39" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indirect bilirubin, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="32"/>
                    <count group_id="O4" value="28"/>
                    <count group_id="O5" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.58" spread="3.59"/>
                    <measurement group_id="O2" value="0.04" spread="3.21"/>
                    <measurement group_id="O3" value="0.38" spread="2.69"/>
                    <measurement group_id="O4" value="-0.36" spread="2.68"/>
                    <measurement group_id="O5" value="-0.37" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indirect bilirubin, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="38"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="3.37"/>
                    <measurement group_id="O2" value="-0.38" spread="3.56"/>
                    <measurement group_id="O3" value="-0.08" spread="2.95"/>
                    <measurement group_id="O4" value="-1.63" spread="3.90"/>
                    <measurement group_id="O5" value="-1.24" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serum creatinine, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="6.78"/>
                    <measurement group_id="O2" value="1.68" spread="8.98"/>
                    <measurement group_id="O3" value="4.27" spread="8.20"/>
                    <measurement group_id="O4" value="5.26" spread="9.20"/>
                    <measurement group_id="O5" value="7.15" spread="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serum creatinine, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.05" spread="6.80"/>
                    <measurement group_id="O2" value="1.00" spread="8.91"/>
                    <measurement group_id="O3" value="2.21" spread="6.97"/>
                    <measurement group_id="O4" value="2.45" spread="8.30"/>
                    <measurement group_id="O5" value="5.83" spread="10.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serum creatinine, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.74" spread="6.97"/>
                    <measurement group_id="O2" value="1.13" spread="10.01"/>
                    <measurement group_id="O3" value="2.57" spread="7.17"/>
                    <measurement group_id="O4" value="2.61" spread="9.49"/>
                    <measurement group_id="O5" value="5.50" spread="8.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serum creatinine, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.12" spread="7.38"/>
                    <measurement group_id="O2" value="1.09" spread="9.24"/>
                    <measurement group_id="O3" value="1.85" spread="9.47"/>
                    <measurement group_id="O4" value="1.03" spread="6.89"/>
                    <measurement group_id="O5" value="2.78" spread="9.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serum creatinine, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.75" spread="7.50"/>
                    <measurement group_id="O2" value="0.07" spread="9.91"/>
                    <measurement group_id="O3" value="0.93" spread="6.87"/>
                    <measurement group_id="O4" value="-1.46" spread="6.89"/>
                    <measurement group_id="O5" value="0.40" spread="8.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="3.72"/>
                    <measurement group_id="O2" value="1.24" spread="3.73"/>
                    <measurement group_id="O3" value="1.77" spread="4.13"/>
                    <measurement group_id="O4" value="1.39" spread="3.78"/>
                    <measurement group_id="O5" value="2.08" spread="6.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="3.16"/>
                    <measurement group_id="O2" value="1.25" spread="4.16"/>
                    <measurement group_id="O3" value="0.73" spread="2.95"/>
                    <measurement group_id="O4" value="1.68" spread="4.87"/>
                    <measurement group_id="O5" value="1.95" spread="4.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="3.75"/>
                    <measurement group_id="O2" value="1.05" spread="3.38"/>
                    <measurement group_id="O3" value="0.83" spread="3.41"/>
                    <measurement group_id="O4" value="1.76" spread="3.97"/>
                    <measurement group_id="O5" value="1.21" spread="4.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.64" spread="4.17"/>
                    <measurement group_id="O2" value="0.17" spread="3.46"/>
                    <measurement group_id="O3" value="0.90" spread="3.39"/>
                    <measurement group_id="O4" value="0.30" spread="4.22"/>
                    <measurement group_id="O5" value="-0.03" spread="5.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.62" spread="4.24"/>
                    <measurement group_id="O2" value="-0.33" spread="3.72"/>
                    <measurement group_id="O3" value="-0.32" spread="3.39"/>
                    <measurement group_id="O4" value="-1.81" spread="5.34"/>
                    <measurement group_id="O5" value="-1.39" spread="3.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="38.94"/>
                    <measurement group_id="O2" value="-8.66" spread="55.20"/>
                    <measurement group_id="O3" value="-22.90" spread="48.36"/>
                    <measurement group_id="O4" value="-20.95" spread="61.72"/>
                    <measurement group_id="O5" value="-26.20" spread="66.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.95" spread="59.07"/>
                    <measurement group_id="O2" value="-13.19" spread="54.16"/>
                    <measurement group_id="O3" value="-20.29" spread="39.59"/>
                    <measurement group_id="O4" value="-11.13" spread="74.79"/>
                    <measurement group_id="O5" value="-7.70" spread="63.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.40" spread="46.23"/>
                    <measurement group_id="O2" value="-3.55" spread="53.46"/>
                    <measurement group_id="O3" value="-21.63" spread="52.20"/>
                    <measurement group_id="O4" value="-13.61" spread="57.87"/>
                    <measurement group_id="O5" value="-13.88" spread="70.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.69" spread="50.16"/>
                    <measurement group_id="O2" value="6.20" spread="74.17"/>
                    <measurement group_id="O3" value="-10.73" spread="41.62"/>
                    <measurement group_id="O4" value="-6.00" spread="61.23"/>
                    <measurement group_id="O5" value="-18.05" spread="82.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" spread="55.55"/>
                    <measurement group_id="O2" value="-8.63" spread="57.75"/>
                    <measurement group_id="O3" value="-4.51" spread="56.60"/>
                    <measurement group_id="O4" value="12.03" spread="59.59"/>
                    <measurement group_id="O5" value="-2.45" spread="57.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Chemistry Parameter of Lipid Profile Over Time</title>
        <description>Assessment for lipid profile was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. The parameters included high density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol and triglycerides. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Chemistry Parameter of Lipid Profile Over Time</title>
          <description>Assessment for lipid profile was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. The parameters included high density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol and triglycerides. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HDL, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.14"/>
                    <measurement group_id="O2" value="0.01" spread="0.19"/>
                    <measurement group_id="O3" value="0.02" spread="0.19"/>
                    <measurement group_id="O4" value="0.05" spread="0.18"/>
                    <measurement group_id="O5" value="-0.03" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.21"/>
                    <measurement group_id="O2" value="0.01" spread="0.17"/>
                    <measurement group_id="O3" value="-0.01" spread="0.20"/>
                    <measurement group_id="O4" value="0.08" spread="0.21"/>
                    <measurement group_id="O5" value="-0.03" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.21"/>
                    <measurement group_id="O2" value="0.02" spread="0.23"/>
                    <measurement group_id="O3" value="0.02" spread="0.19"/>
                    <measurement group_id="O4" value="0.05" spread="0.14"/>
                    <measurement group_id="O5" value="-0.04" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.24"/>
                    <measurement group_id="O2" value="-0.02" spread="0.20"/>
                    <measurement group_id="O3" value="-0.04" spread="0.20"/>
                    <measurement group_id="O4" value="0.01" spread="0.18"/>
                    <measurement group_id="O5" value="-0.05" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.22"/>
                    <measurement group_id="O2" value="0.00" spread="0.17"/>
                    <measurement group_id="O3" value="-0.01" spread="0.22"/>
                    <measurement group_id="O4" value="0.05" spread="0.15"/>
                    <measurement group_id="O5" value="-0.01" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.57"/>
                    <measurement group_id="O2" value="-0.27" spread="0.76"/>
                    <measurement group_id="O3" value="-0.16" spread="0.57"/>
                    <measurement group_id="O4" value="-0.19" spread="0.45"/>
                    <measurement group_id="O5" value="-0.20" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.53"/>
                    <measurement group_id="O2" value="-0.26" spread="0.83"/>
                    <measurement group_id="O3" value="-0.23" spread="0.76"/>
                    <measurement group_id="O4" value="-0.22" spread="0.61"/>
                    <measurement group_id="O5" value="-0.26" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.68"/>
                    <measurement group_id="O2" value="-0.34" spread="0.67"/>
                    <measurement group_id="O3" value="-0.14" spread="0.88"/>
                    <measurement group_id="O4" value="-0.23" spread="0.52"/>
                    <measurement group_id="O5" value="-0.17" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.69"/>
                    <measurement group_id="O2" value="-0.17" spread="0.77"/>
                    <measurement group_id="O3" value="-0.29" spread="0.75"/>
                    <measurement group_id="O4" value="-0.28" spread="0.59"/>
                    <measurement group_id="O5" value="-0.22" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LDL, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.71"/>
                    <measurement group_id="O2" value="-0.30" spread="0.83"/>
                    <measurement group_id="O3" value="-0.14" spread="0.77"/>
                    <measurement group_id="O4" value="-0.15" spread="0.50"/>
                    <measurement group_id="O5" value="-0.07" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total cholesterol, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.62"/>
                    <measurement group_id="O2" value="-0.33" spread="0.89"/>
                    <measurement group_id="O3" value="-0.27" spread="0.72"/>
                    <measurement group_id="O4" value="-0.38" spread="0.50"/>
                    <measurement group_id="O5" value="-0.27" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total cholesterol, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.71"/>
                    <measurement group_id="O2" value="-0.38" spread="0.97"/>
                    <measurement group_id="O3" value="-0.27" spread="0.98"/>
                    <measurement group_id="O4" value="-0.35" spread="0.82"/>
                    <measurement group_id="O5" value="-0.27" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total cholesterol, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.92"/>
                    <measurement group_id="O2" value="-0.46" spread="0.81"/>
                    <measurement group_id="O3" value="-0.16" spread="1.06"/>
                    <measurement group_id="O4" value="-0.49" spread="0.81"/>
                    <measurement group_id="O5" value="-0.20" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total cholesterol, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.97"/>
                    <measurement group_id="O2" value="-0.23" spread="0.93"/>
                    <measurement group_id="O3" value="-0.25" spread="0.89"/>
                    <measurement group_id="O4" value="-0.55" spread="0.81"/>
                    <measurement group_id="O5" value="-0.23" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total cholesterol, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.98"/>
                    <measurement group_id="O2" value="-0.47" spread="0.88"/>
                    <measurement group_id="O3" value="-0.22" spread="1.07"/>
                    <measurement group_id="O4" value="-0.41" spread="0.93"/>
                    <measurement group_id="O5" value="-0.11" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.93"/>
                    <measurement group_id="O2" value="-0.14" spread="1.12"/>
                    <measurement group_id="O3" value="-0.22" spread="0.76"/>
                    <measurement group_id="O4" value="-0.66" spread="1.33"/>
                    <measurement group_id="O5" value="-0.13" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="1.05"/>
                    <measurement group_id="O2" value="-0.34" spread="1.36"/>
                    <measurement group_id="O3" value="0.02" spread="1.23"/>
                    <measurement group_id="O4" value="-0.50" spread="0.97"/>
                    <measurement group_id="O5" value="0.07" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="1.03"/>
                    <measurement group_id="O2" value="-0.36" spread="1.30"/>
                    <measurement group_id="O3" value="-0.02" spread="0.97"/>
                    <measurement group_id="O4" value="-0.83" spread="1.89"/>
                    <measurement group_id="O5" value="0.08" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="1.06"/>
                    <measurement group_id="O2" value="-0.09" spread="1.60"/>
                    <measurement group_id="O3" value="0.22" spread="0.95"/>
                    <measurement group_id="O4" value="-0.75" spread="1.91"/>
                    <measurement group_id="O5" value="0.03" spread="1.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.83"/>
                    <measurement group_id="O2" value="-0.30" spread="0.81"/>
                    <measurement group_id="O3" value="-0.32" spread="3.03"/>
                    <measurement group_id="O4" value="-0.90" spread="2.29"/>
                    <measurement group_id="O5" value="-0.19" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Chemistry Parameter of Albumin and Total Protein Over Time</title>
        <description>Assessment for albumin and total protein were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Chemistry Parameter of Albumin and Total Protein Over Time</title>
          <description>Assessment for albumin and total protein were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Gram per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Albumin, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="2.03"/>
                    <measurement group_id="O2" value="0.80" spread="2.40"/>
                    <measurement group_id="O3" value="0.78" spread="2.72"/>
                    <measurement group_id="O4" value="0.64" spread="2.05"/>
                    <measurement group_id="O5" value="1.02" spread="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="2.44"/>
                    <measurement group_id="O2" value="1.05" spread="2.39"/>
                    <measurement group_id="O3" value="0.29" spread="2.39"/>
                    <measurement group_id="O4" value="0.13" spread="2.24"/>
                    <measurement group_id="O5" value="0.53" spread="2.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="1.91"/>
                    <measurement group_id="O2" value="0.82" spread="2.46"/>
                    <measurement group_id="O3" value="0.10" spread="2.34"/>
                    <measurement group_id="O4" value="0.55" spread="2.37"/>
                    <measurement group_id="O5" value="0.40" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" spread="2.15"/>
                    <measurement group_id="O2" value="0.00" spread="2.45"/>
                    <measurement group_id="O3" value="-0.63" spread="2.79"/>
                    <measurement group_id="O4" value="-0.32" spread="2.24"/>
                    <measurement group_id="O5" value="-0.53" spread="2.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="2.59"/>
                    <measurement group_id="O2" value="-0.07" spread="2.08"/>
                    <measurement group_id="O3" value="-0.17" spread="2.56"/>
                    <measurement group_id="O4" value="-0.16" spread="2.48"/>
                    <measurement group_id="O5" value="-0.21" spread="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein, Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="3.33"/>
                    <measurement group_id="O2" value="1.24" spread="4.39"/>
                    <measurement group_id="O3" value="0.23" spread="4.29"/>
                    <measurement group_id="O4" value="0.21" spread="3.15"/>
                    <measurement group_id="O5" value="1.24" spread="4.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein, Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="4.43"/>
                    <measurement group_id="O2" value="0.67" spread="4.68"/>
                    <measurement group_id="O3" value="0.63" spread="4.92"/>
                    <measurement group_id="O4" value="-1.24" spread="4.28"/>
                    <measurement group_id="O5" value="-0.03" spread="4.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein, Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="3.21"/>
                    <measurement group_id="O2" value="1.29" spread="5.54"/>
                    <measurement group_id="O3" value="0.49" spread="4.90"/>
                    <measurement group_id="O4" value="0.18" spread="3.81"/>
                    <measurement group_id="O5" value="-0.03" spread="3.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein, Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="3.76"/>
                    <measurement group_id="O2" value="0.06" spread="5.17"/>
                    <measurement group_id="O3" value="-1.10" spread="5.45"/>
                    <measurement group_id="O4" value="-0.63" spread="3.76"/>
                    <measurement group_id="O5" value="-1.49" spread="4.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein, Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="4.03"/>
                    <measurement group_id="O2" value="-0.61" spread="3.94"/>
                    <measurement group_id="O3" value="-0.07" spread="4.66"/>
                    <measurement group_id="O4" value="-0.95" spread="4.16"/>
                    <measurement group_id="O5" value="-1.57" spread="4.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Urinalysis Parameter of Specific Gravity Over Time</title>
        <description>Urinary specific gravity is a measure of the concentration of solutes in urine. It measures the ratio of urine density compared with water density and provides information on the kidney's ability to concentrate urine. The assessments were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Urinalysis Parameter of Specific Gravity Over Time</title>
          <description>Urinary specific gravity is a measure of the concentration of solutes in urine. It measures the ratio of urine density compared with water density and provides information on the kidney's ability to concentrate urine. The assessments were performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.01"/>
                    <measurement group_id="O2" value="-0.00" spread="0.01"/>
                    <measurement group_id="O3" value="0.00" spread="0.01"/>
                    <measurement group_id="O4" value="-0.00" spread="0.01"/>
                    <measurement group_id="O5" value="-0.00" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.01"/>
                    <measurement group_id="O2" value="-0.00" spread="0.00"/>
                    <measurement group_id="O3" value="-0.00" spread="0.01"/>
                    <measurement group_id="O4" value="-0.00" spread="0.01"/>
                    <measurement group_id="O5" value="0.00" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.01"/>
                    <measurement group_id="O2" value="-0.00" spread="0.01"/>
                    <measurement group_id="O3" value="0.00" spread="0.01"/>
                    <measurement group_id="O4" value="-0.00" spread="0.01"/>
                    <measurement group_id="O5" value="0.00" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.01"/>
                    <measurement group_id="O2" value="-0.00" spread="0.01"/>
                    <measurement group_id="O3" value="0.00" spread="0.01"/>
                    <measurement group_id="O4" value="-0.00" spread="0.01"/>
                    <measurement group_id="O5" value="0.00" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.01"/>
                    <measurement group_id="O2" value="-0.00" spread="0.01"/>
                    <measurement group_id="O3" value="0.00" spread="0.01"/>
                    <measurement group_id="O4" value="-0.00" spread="0.01"/>
                    <measurement group_id="O5" value="-0.00" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Urinalysis Parameter of pH Over Time</title>
        <description>Urinalysis parameter included urine pH. pH was calculated on a scale of 0 to 14, such that, the lower the number, more acidic the urine and higher the number, more alkaline the urine with 7 being neutral. The assessment was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Urinalysis Parameter of pH Over Time</title>
          <description>Urinalysis parameter included urine pH. pH was calculated on a scale of 0 to 14, such that, the lower the number, more acidic the urine and higher the number, more alkaline the urine with 7 being neutral. The assessment was performed on Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>Safety Analysis Set Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Points on scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.34"/>
                    <measurement group_id="O2" value="-0.05" spread="0.38"/>
                    <measurement group_id="O3" value="-0.02" spread="0.35"/>
                    <measurement group_id="O4" value="0.00" spread="0.43"/>
                    <measurement group_id="O5" value="0.10" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.35"/>
                    <measurement group_id="O2" value="-0.04" spread="0.45"/>
                    <measurement group_id="O3" value="-0.05" spread="0.57"/>
                    <measurement group_id="O4" value="0.11" spread="0.47"/>
                    <measurement group_id="O5" value="0.08" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.41"/>
                    <measurement group_id="O2" value="-0.03" spread="0.50"/>
                    <measurement group_id="O3" value="0.01" spread="0.55"/>
                    <measurement group_id="O4" value="0.05" spread="0.40"/>
                    <measurement group_id="O5" value="-0.03" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.66"/>
                    <measurement group_id="O2" value="-0.09" spread="0.43"/>
                    <measurement group_id="O3" value="0.00" spread="0.59"/>
                    <measurement group_id="O4" value="0.03" spread="0.37"/>
                    <measurement group_id="O5" value="0.04" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.48"/>
                    <measurement group_id="O2" value="-0.15" spread="0.37"/>
                    <measurement group_id="O3" value="-0.12" spread="0.55"/>
                    <measurement group_id="O4" value="0.01" spread="0.38"/>
                    <measurement group_id="O5" value="0.07" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Area Under Plasma Concentration Curve From Time 0 to Last Measurable Time Point (AUC 0-t), From Time 0 to Infinity (AUC 0-infinity) and From Time 0 to Trough Concentration (AUC 0-τ) of SRT2104 on Day 1 and Day 28</title>
        <description>The pre-dose blood samples were collected within one hour prior to study medication administration. The post-dose blood samples were collected within 2 minutes of the scheduled time. AUC values reported in the analysis of AUC 0-infinity of Day 28 versus Day 1 included AUC 0-infinity on Day 1 and AUC 0-τ on Day 28. Participants fasted for at least 10 hour overnight on Day 1, 2 and 29. The AUC 0-t was determined using the linear trapezoidal rule for increasing concentrations and the logarithmic trapezoidal rule for decreasing concentrations. AUC0-infinity was estimated by linear trapezoidal rule and was sum of the AUC0-t and extrapolated to infinity by dividing the estimated last measurable plasma concentration by elimination rate constant lambda z. Where lambda z is the terminal phase rate constant estimated by linear regression analysis of the log10 transformed concentration-time data after each single dose. The AUC0-infinity was the sum of the estimated and extrapolated parts.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28)</time_frame>
        <population>Pharmacokinetic (PK) Population defined as all participants who received SRT2104, had sufficient blood samples taken to obtain a plasma concentration time profile and who did not violate the protocol in such a way that it could influence the statistical analysis. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under Plasma Concentration Curve From Time 0 to Last Measurable Time Point (AUC 0-t), From Time 0 to Infinity (AUC 0-infinity) and From Time 0 to Trough Concentration (AUC 0-τ) of SRT2104 on Day 1 and Day 28</title>
          <description>The pre-dose blood samples were collected within one hour prior to study medication administration. The post-dose blood samples were collected within 2 minutes of the scheduled time. AUC values reported in the analysis of AUC 0-infinity of Day 28 versus Day 1 included AUC 0-infinity on Day 1 and AUC 0-τ on Day 28. Participants fasted for at least 10 hour overnight on Day 1, 2 and 29. The AUC 0-t was determined using the linear trapezoidal rule for increasing concentrations and the logarithmic trapezoidal rule for decreasing concentrations. AUC0-infinity was estimated by linear trapezoidal rule and was sum of the AUC0-t and extrapolated to infinity by dividing the estimated last measurable plasma concentration by elimination rate constant lambda z. Where lambda z is the terminal phase rate constant estimated by linear regression analysis of the log10 transformed concentration-time data after each single dose. The AUC0-infinity was the sum of the estimated and extrapolated parts.</description>
          <population>Pharmacokinetic (PK) Population defined as all participants who received SRT2104, had sufficient blood samples taken to obtain a plasma concentration time profile and who did not violate the protocol in such a way that it could influence the statistical analysis. Only those participants available at the specified time points were analyzed.</population>
          <units>Nanogram (ng)*hour/milliliter (mL)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, AUC 0-t</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1045.8420" spread="978.3355"/>
                    <measurement group_id="O2" value="2153.0075" spread="1835.6039"/>
                    <measurement group_id="O3" value="2375.3150" spread="2285.7123"/>
                    <measurement group_id="O4" value="2859.5465" spread="2916.4783"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-t</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1549.6139" spread="1450.1354"/>
                    <measurement group_id="O2" value="2731.6308" spread="2337.0839"/>
                    <measurement group_id="O3" value="3109.8747" spread="2948.2780"/>
                    <measurement group_id="O4" value="4380.2204" spread="4476.9484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, AUC 0-infinity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="30"/>
                    <count group_id="O4" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1564.4905" spread="1119.3480"/>
                    <measurement group_id="O2" value="2797.6930" spread="2287.3141"/>
                    <measurement group_id="O3" value="3080.6902" spread="2532.8224"/>
                    <measurement group_id="O4" value="3837.1384" spread="4078.6970"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-infinity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="27"/>
                    <count group_id="O4" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2289.6858" spread="1876.6537"/>
                    <measurement group_id="O2" value="4634.3397" spread="5387.2429"/>
                    <measurement group_id="O3" value="4960.3422" spread="3914.0260"/>
                    <measurement group_id="O4" value="8159.4534" spread="7592.2760"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-τ</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1620.5989" spread="1431.4150"/>
                    <measurement group_id="O2" value="2731.6231" spread="2337.0919"/>
                    <measurement group_id="O3" value="3212.6640" spread="2924.1860"/>
                    <measurement group_id="O4" value="4584.5679" spread="4502.8752"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-t of SRT2104 0.25 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>168.40</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>123.87</ci_lower_limit>
            <ci_upper_limit>228.94</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding confidence interval (CI) were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-infinity of SRT2104 0.25 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>110.88</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>88.18</ci_lower_limit>
            <ci_upper_limit>139.43</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI. AUC values included in the analysis were AUC 0-infinity on Day 1 and AUC 0-τ on Day 28.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-t of SRT2104 0.5 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>133.11</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>100.55</ci_lower_limit>
            <ci_upper_limit>176.21</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-infinity of SRT2104 0.5 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Other</param_type>
            <param_value>94.30</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>70.31</ci_lower_limit>
            <ci_upper_limit>126.48</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI. The AUC values included in the analysis were AUC 0-infinity on Day 1 and AUC 0-τ on Day 28.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-t of SRT2104 1.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>141.63</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>111.20</ci_lower_limit>
            <ci_upper_limit>180.39</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1for AUC 0-infinity of SRT2104 1.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>114.46</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>85.56</ci_lower_limit>
            <ci_upper_limit>153.11</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI. The AUC values included in the analysis were AUC 0-infinity on Day 1 and AUC 0-τ on Day 28.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-t of SRT2104 2.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>167.09</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>120.73</ci_lower_limit>
            <ci_upper_limit>231.25</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for AUC 0-infinity of SRT2104 2.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>117.73</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>85.14</ci_lower_limit>
            <ci_upper_limit>162.79</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI. The AUC values included in the analysis were AUC 0-infinity on Day 1 and AUC 0-τ on Day 28.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Maximum Plasma Concentration (Cmax) of SRT2104 at Day 1 and Day 28</title>
        <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. On Day 1, Day 2 and Day 29, participants fasted for at least 10 hour overnight. The post-dose sample was collected within 2 minutes of the scheduled time. The first occurrence of the Cmax was determined directly from the raw concentration-time data.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
        <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Maximum Plasma Concentration (Cmax) of SRT2104 at Day 1 and Day 28</title>
          <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. On Day 1, Day 2 and Day 29, participants fasted for at least 10 hour overnight. The post-dose sample was collected within 2 minutes of the scheduled time. The first occurrence of the Cmax was determined directly from the raw concentration-time data.</description>
          <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="178.729" spread="179.982"/>
                    <measurement group_id="O2" value="366.694" spread="322.951"/>
                    <measurement group_id="O3" value="336.562" spread="298.042"/>
                    <measurement group_id="O4" value="417.832" spread="470.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="185.418" spread="162.500"/>
                    <measurement group_id="O2" value="329.973" spread="266.174"/>
                    <measurement group_id="O3" value="375.395" spread="333.188"/>
                    <measurement group_id="O4" value="433.650" spread="461.441"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for Cmax of SRT2104 0.25 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>122.22</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>86.94</ci_lower_limit>
            <ci_upper_limit>171.80</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for Cmax of SRT2104 0.5 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>94.45</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>69.07</ci_lower_limit>
            <ci_upper_limit>129.16</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for Cmax of SRT2104 1.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>114.79</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>91.54</ci_lower_limit>
            <ci_upper_limit>143.95</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Day 28 versus Day 1 for Cmax of SRT2104 2.0 g/day.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The analysis used an Estimation approach. No hypothesis testing was performed.</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>120.30</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>88.66</ci_lower_limit>
            <ci_upper_limit>163.23</ci_upper_limit>
            <estimate_desc>The difference in least squares means and corresponding CI were back-transformed to form ratio of geometric least squares means (Day 28/ Day 1) and CI.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Cmax (Tmax) at Day 1 and Day 28</title>
        <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. The time at which Cmax was observed was determined directly from the raw concentration-time data.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
        <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Cmax (Tmax) at Day 1 and Day 28</title>
          <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. The time at which Cmax was observed was determined directly from the raw concentration-time data.</description>
          <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.000" lower_limit="2.000" upper_limit="8.000"/>
                    <measurement group_id="O2" value="3.000" lower_limit="1.000" upper_limit="24.000"/>
                    <measurement group_id="O3" value="3.000" lower_limit="2.000" upper_limit="8.000"/>
                    <measurement group_id="O4" value="4.000" lower_limit="0.250" upper_limit="12.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.000" lower_limit="0.000" upper_limit="24.000"/>
                    <measurement group_id="O2" value="3.000" lower_limit="0.000" upper_limit="12.000"/>
                    <measurement group_id="O3" value="3.000" lower_limit="0.000" upper_limit="24.000"/>
                    <measurement group_id="O4" value="3.000" lower_limit="0.000" upper_limit="12.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Terminal Elimination Half Life (T1/2) of SRT2104 at Day 1 and Day 28</title>
        <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight. The t1/2 was obtained as the ratio of ln2/λz, where λz is the terminal phase rate constant estimated by linear regression analysis of the concentration-time data.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
        <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Terminal Elimination Half Life (T1/2) of SRT2104 at Day 1 and Day 28</title>
          <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight. The t1/2 was obtained as the ratio of ln2/λz, where λz is the terminal phase rate constant estimated by linear regression analysis of the concentration-time data.</description>
          <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="30"/>
                    <count group_id="O4" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.4184" lower_limit="4.0113" upper_limit="33.0069"/>
                    <measurement group_id="O2" value="12.1669" lower_limit="6.1089" upper_limit="40.6904"/>
                    <measurement group_id="O3" value="13.3434" lower_limit="6.4721" upper_limit="54.7509"/>
                    <measurement group_id="O4" value="9.7846" lower_limit="3.8100" upper_limit="24.2013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="27"/>
                    <count group_id="O4" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.0115" lower_limit="7.1058" upper_limit="31.3329"/>
                    <measurement group_id="O2" value="20.3500" lower_limit="7.3262" upper_limit="66.2388"/>
                    <measurement group_id="O3" value="18.9258" lower_limit="7.6823" upper_limit="42.6557"/>
                    <measurement group_id="O4" value="17.4548" lower_limit="9.0649" upper_limit="42.0806"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Apparent Total Clearance of SRT2104 From Plasma After Oral Administration (CL/F) on Day 1 and Day 28</title>
        <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
        <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Total Clearance of SRT2104 From Plasma After Oral Administration (CL/F) on Day 1 and Day 28</title>
          <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
          <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Liter/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="30"/>
                    <count group_id="O4" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="494.0236" spread="625.5532"/>
                    <measurement group_id="O2" value="621.3930" spread="948.1533"/>
                    <measurement group_id="O3" value="1582.0131" spread="2707.3466"/>
                    <measurement group_id="O4" value="2181.8596" spread="2959.1044"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="631.5519" spread="900.3648"/>
                    <measurement group_id="O2" value="956.6848" spread="2117.3623"/>
                    <measurement group_id="O3" value="1420.2734" spread="2128.7769"/>
                    <measurement group_id="O4" value="1887.2455" spread="2883.3080"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Apparent Volume of Distribution After Oral Administration (Vd/F) at Day 1 and Day 28</title>
        <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
        <time_frame>Day 1 (pre-dose, 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8, 15 and 22 (pre-dose), Day 28 (pre-dose, and 15 and 30 minutes, 1, 2, 3, 4, 8 and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose)</time_frame>
        <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Volume of Distribution After Oral Administration (Vd/F) at Day 1 and Day 28</title>
          <description>Blood samples were collected on Day 1 (pre-dose, 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose), Day 2 (24 hour post-Day 1 dose), Day 8 (pre-dose), Day 15 (pre-dose), Day 22 (pre-dose), Day 28 (pre-dose, and 15 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 8 hour and 12 hour post-dose) and Day 29 (24 hour post-Day 28 dose). The pre-dose sample was collected within one hour prior to study medication administration. The post-dose sample was collected within 2 minutes of the scheduled time. On Day 1 Day 2 and Day 29, participants fasted for at least 10 hour overnight.</description>
          <population>PK Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mL/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="30"/>
                    <count group_id="O4" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12921.7880" spread="19802.8598"/>
                    <measurement group_id="O2" value="15767.2219" spread="29059.7570"/>
                    <measurement group_id="O3" value="38320.97415" spread="77339.06047"/>
                    <measurement group_id="O4" value="32262.5089" spread="45180.0346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="27"/>
                    <count group_id="O4" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17509.8071" spread="27627.2504"/>
                    <measurement group_id="O2" value="48475.7739" spread="150725.4900"/>
                    <measurement group_id="O3" value="56531.7676" spread="108327.3925"/>
                    <measurement group_id="O4" value="51594.5474" spread="93165.0710"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Fasting Plasma Glucose (FPG) Levels Over Time</title>
        <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
        <time_frame>Up to Day 35</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Fasting Plasma Glucose (FPG) Levels Over Time</title>
          <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.46" spread="2.60"/>
                    <measurement group_id="O2" value="10.33" spread="2.30"/>
                    <measurement group_id="O3" value="11.10" spread="2.33"/>
                    <measurement group_id="O4" value="10.67" spread="2.19"/>
                    <measurement group_id="O5" value="10.37" spread="2.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.08" spread="2.46"/>
                    <measurement group_id="O2" value="10.52" spread="2.40"/>
                    <measurement group_id="O3" value="10.51" spread="2.39"/>
                    <measurement group_id="O4" value="10.37" spread="2.30"/>
                    <measurement group_id="O5" value="10.41" spread="2.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.03" spread="2.03"/>
                    <measurement group_id="O2" value="10.31" spread="2.66"/>
                    <measurement group_id="O3" value="11.24" spread="2.17"/>
                    <measurement group_id="O4" value="10.59" spread="2.35"/>
                    <measurement group_id="O5" value="10.56" spread="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.60" spread="2.02"/>
                    <measurement group_id="O2" value="10.21" spread="2.12"/>
                    <measurement group_id="O3" value="10.49" spread="2.22"/>
                    <measurement group_id="O4" value="10.32" spread="2.16"/>
                    <measurement group_id="O5" value="10.05" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.10" spread="2.41"/>
                    <measurement group_id="O2" value="10.10" spread="2.21"/>
                    <measurement group_id="O3" value="9.92" spread="2.04"/>
                    <measurement group_id="O4" value="9.51" spread="2.62"/>
                    <measurement group_id="O5" value="9.03" spread="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 8 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.997</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 8 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.581</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 8 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.987</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 8 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 15 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.850</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 15 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.843</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 15 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.961</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 15 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.939</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 22 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.966</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 22 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.075</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 22 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.700</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 22 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.732</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 28 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.552</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 28 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.196</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 28 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.393</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 28 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.775</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 35 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 35 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 35 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.603</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 35 for FPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.108</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in FPG Levels Over Time</title>
        <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in FPG Levels Over Time</title>
          <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="2.20"/>
                    <measurement group_id="O2" value="-1.00" spread="3.23"/>
                    <measurement group_id="O3" value="0.16" spread="2.06"/>
                    <measurement group_id="O4" value="-0.41" spread="2.77"/>
                    <measurement group_id="O5" value="0.17" spread="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.72" spread="2.45"/>
                    <measurement group_id="O2" value="-0.91" spread="2.61"/>
                    <measurement group_id="O3" value="-0.41" spread="2.35"/>
                    <measurement group_id="O4" value="-0.64" spread="2.78"/>
                    <measurement group_id="O5" value="0.17" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.74" spread="2.48"/>
                    <measurement group_id="O2" value="-1.06" spread="3.63"/>
                    <measurement group_id="O3" value="0.28" spread="2.79"/>
                    <measurement group_id="O4" value="-0.47" spread="2.90"/>
                    <measurement group_id="O5" value="0.40" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.17" spread="2.42"/>
                    <measurement group_id="O2" value="-1.11" spread="3.45"/>
                    <measurement group_id="O3" value="-0.52" spread="2.60"/>
                    <measurement group_id="O4" value="-0.97" spread="2.83"/>
                    <measurement group_id="O5" value="-0.15" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.73" spread="2.70"/>
                    <measurement group_id="O2" value="-0.94" spread="2.47"/>
                    <measurement group_id="O3" value="-1.24" spread="3.07"/>
                    <measurement group_id="O4" value="-1.52" spread="3.29"/>
                    <measurement group_id="O5" value="-1.14" spread="2.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPG on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.525</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPG on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.818</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPG on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPG on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.809</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPG on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.993</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPG on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.954</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPG on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPG on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.344</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPG on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.968</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPG on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.316</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPG on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.984</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPG on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.235</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPG on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPG on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.656</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPG on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.994</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPG on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.285</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPG on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.992</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPG on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.822</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPG on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.538</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPG on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.907</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Fasting Plasma Insulin (FPI) Levels Over Time</title>
        <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
        <time_frame>Up to Day 35</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Fasting Plasma Insulin (FPI) Levels Over Time</title>
          <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.9" spread="59.63"/>
                    <measurement group_id="O2" value="92.3" spread="95.57"/>
                    <measurement group_id="O3" value="83.8" spread="52.19"/>
                    <measurement group_id="O4" value="74.5" spread="61.77"/>
                    <measurement group_id="O5" value="74.4" spread="51.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.0" spread="70.89"/>
                    <measurement group_id="O2" value="78.4" spread="93.50"/>
                    <measurement group_id="O3" value="80.4" spread="45.86"/>
                    <measurement group_id="O4" value="80.5" spread="76.39"/>
                    <measurement group_id="O5" value="79.3" spread="89.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.7" spread="98.55"/>
                    <measurement group_id="O2" value="74.3" spread="93.51"/>
                    <measurement group_id="O3" value="81.8" spread="47.79"/>
                    <measurement group_id="O4" value="78.8" spread="65.46"/>
                    <measurement group_id="O5" value="76.8" spread="57.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.4" spread="56.91"/>
                    <measurement group_id="O2" value="91.7" spread="118.05"/>
                    <measurement group_id="O3" value="63.7" spread="44.87"/>
                    <measurement group_id="O4" value="63.3" spread="55.69"/>
                    <measurement group_id="O5" value="89.2" spread="134.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101.6" spread="70.49"/>
                    <measurement group_id="O2" value="110.5" spread="157.53"/>
                    <measurement group_id="O3" value="87.1" spread="56.22"/>
                    <measurement group_id="O4" value="84.0" spread="78.95"/>
                    <measurement group_id="O5" value="115.3" spread="213.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 8 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 8 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.982</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 8 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.677</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 8 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.688</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 15 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.903</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 15 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.945</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 15 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.949</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 15 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.924</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 22 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.394</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 22 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.687</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 22 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.568</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 22 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.486</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 28 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.973</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 28 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.739</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 28 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.731</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 28 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.991</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day on Day 35 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.994</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day on Day 35 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.963</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day on Day 35 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.929</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day on Day 35 for FPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.970</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in FPI Over Time</title>
        <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
        <time_frame>Baseline (Day 1) and up to Day 35</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in FPI Over Time</title>
          <description>The assessments were done at Day 1, Day 8, Day 15, Day 22, Day 28 and Day 35 weekly at central laboratory. Baseline was defined as the assessment done on Day 1. The analysis was reported for Day 8, Day 15, Day 22, Day 28 and Day 35. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 8, Day 15, Day 22, Day 28 and Day 35) values.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="66.75"/>
                    <measurement group_id="O2" value="12.2" spread="80.20"/>
                    <measurement group_id="O3" value="12.3" spread="49.91"/>
                    <measurement group_id="O4" value="12.9" spread="63.97"/>
                    <measurement group_id="O5" value="4.7" spread="37.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8" spread="77.13"/>
                    <measurement group_id="O2" value="-6.5" spread="48.51"/>
                    <measurement group_id="O3" value="8.1" spread="45.43"/>
                    <measurement group_id="O4" value="18.8" spread="88.06"/>
                    <measurement group_id="O5" value="8.3" spread="96.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.6" spread="90.89"/>
                    <measurement group_id="O2" value="-4.6" spread="55.62"/>
                    <measurement group_id="O3" value="10.6" spread="56.34"/>
                    <measurement group_id="O4" value="20.2" spread="75.69"/>
                    <measurement group_id="O5" value="0.3" spread="49.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="51.66"/>
                    <measurement group_id="O2" value="8.9" spread="95.04"/>
                    <measurement group_id="O3" value="-6.9" spread="41.45"/>
                    <measurement group_id="O4" value="4.1" spread="57.16"/>
                    <measurement group_id="O5" value="15.2" spread="138.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.4" spread="80.92"/>
                    <measurement group_id="O2" value="30.7" spread="103.55"/>
                    <measurement group_id="O3" value="13.7" spread="47.92"/>
                    <measurement group_id="O4" value="22.3" spread="79.42"/>
                    <measurement group_id="O5" value="48.0" spread="216.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPI on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPI on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPI on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.982</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPI on Day 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPI on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.685</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPI on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPI on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.971</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPI on Day 15.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPI on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.405</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPI on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.975</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPI on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPI on Day 22.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.629</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPI on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.982</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPI on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.982</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPI on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPI on Day 28.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.874</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in FPI on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.986</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in FPI on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.997</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in FPI on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in FPI on Day 35.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.697</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Post-prandial Glucose (PPG) and Post-prandial Insulin (PPI) Levels at Day 28</title>
        <description>The assessment of PPG and PPI was performed on Day 28 at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast).</description>
        <time_frame>Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Post-prandial Glucose (PPG) and Post-prandial Insulin (PPI) Levels at Day 28</title>
          <description>The assessment of PPG and PPI was performed on Day 28 at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast).</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PPG, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.91" spread="2.94"/>
                    <measurement group_id="O2" value="12.95" spread="2.66"/>
                    <measurement group_id="O3" value="13.58" spread="3.05"/>
                    <measurement group_id="O4" value="13.12" spread="2.90"/>
                    <measurement group_id="O5" value="11.41" spread="2.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPG, 60 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="29"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.05" spread="3.13"/>
                    <measurement group_id="O2" value="14.05" spread="3.57"/>
                    <measurement group_id="O3" value="15.44" spread="3.05"/>
                    <measurement group_id="O4" value="14.77" spread="3.16"/>
                    <measurement group_id="O5" value="13.08" spread="3.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPG, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.16" spread="4.26"/>
                    <measurement group_id="O2" value="13.15" spread="3.55"/>
                    <measurement group_id="O3" value="14.74" spread="3.15"/>
                    <measurement group_id="O4" value="13.90" spread="3.60"/>
                    <measurement group_id="O5" value="13.61" spread="4.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="28"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="237.6" spread="222.95"/>
                    <measurement group_id="O2" value="217.2" spread="198.91"/>
                    <measurement group_id="O3" value="188.3" spread="172.53"/>
                    <measurement group_id="O4" value="160.2" spread="153.46"/>
                    <measurement group_id="O5" value="163.0" spread="179.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 60 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="298.1" spread="232.43"/>
                    <measurement group_id="O2" value="285.4" spread="339.90"/>
                    <measurement group_id="O3" value="223.0" spread="167.72"/>
                    <measurement group_id="O4" value="189.2" spread="145.83"/>
                    <measurement group_id="O5" value="226.6" spread="200.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="224.4" spread="129.69"/>
                    <measurement group_id="O2" value="215.0" spread="309.78"/>
                    <measurement group_id="O3" value="192.5" spread="132.93"/>
                    <measurement group_id="O4" value="183.8" spread="160.20"/>
                    <measurement group_id="O5" value="206.4" spread="202.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 30 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 30 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.812</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 30 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.996</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 30 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.198</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 60 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 60 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.358</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 60 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.852</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 60 minutes for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.678</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 2 hour for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 2 hour for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.191</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 2 hour for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.805</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 2 hour for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.960</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 30 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.985</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 30 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.733</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 30 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.365</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 30 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.413</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 60 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.765</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 60 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.434</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 60 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.184</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 60 minutes for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.142</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at 2 hour for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at 2 hour for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.876</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at 2 hour for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.756</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at 2 hour for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.983</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in PPG and PPI Levels at Day 28</title>
        <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. Baseline for PPG was defined as the assessment value of FPG done on Day 1 and Baseline for PPI was defined as the assessment value of FPI done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (30 min, 60 min and 2 h at Day 28) values.</description>
        <time_frame>Baseline (Day 1) and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in PPG and PPI Levels at Day 28</title>
          <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. Baseline for PPG was defined as the assessment value of FPG done on Day 1 and Baseline for PPI was defined as the assessment value of FPI done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (30 min, 60 min and 2 h at Day 28) values.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PPG, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="25"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.38" spread="2.85"/>
                    <measurement group_id="O2" value="2.82" spread="2.40"/>
                    <measurement group_id="O3" value="3.40" spread="2.52"/>
                    <measurement group_id="O4" value="3.14" spread="1.75"/>
                    <measurement group_id="O5" value="2.00" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPG, 60 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="29"/>
                    <count group_id="O4" value="25"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.53" spread="2.86"/>
                    <measurement group_id="O2" value="3.92" spread="3.55"/>
                    <measurement group_id="O3" value="5.12" spread="2.57"/>
                    <measurement group_id="O4" value="4.74" spread="2.34"/>
                    <measurement group_id="O5" value="3.68" spread="3.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPG, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.56" spread="3.37"/>
                    <measurement group_id="O2" value="2.93" spread="3.33"/>
                    <measurement group_id="O3" value="4.23" spread="2.88"/>
                    <measurement group_id="O4" value="3.66" spread="2.54"/>
                    <measurement group_id="O5" value="3.47" spread="3.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 30 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="28"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162.4" spread="204.29"/>
                    <measurement group_id="O2" value="108.7" spread="136.13"/>
                    <measurement group_id="O3" value="119.2" spread="157.32"/>
                    <measurement group_id="O4" value="94.9" spread="109.96"/>
                    <measurement group_id="O5" value="57.4" spread="73.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 60 minutes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222.9" spread="206.99"/>
                    <measurement group_id="O2" value="176.9" spread="278.91"/>
                    <measurement group_id="O3" value="153.9" spread="146.74"/>
                    <measurement group_id="O4" value="128.4" spread="105.95"/>
                    <measurement group_id="O5" value="121.0" spread="95.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPI, 2 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.0" spread="113.58"/>
                    <measurement group_id="O2" value="123.3" spread="253.84"/>
                    <measurement group_id="O3" value="128.7" spread="106.87"/>
                    <measurement group_id="O4" value="120.5" spread="129.95"/>
                    <measurement group_id="O5" value="117.3" spread="127.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPG at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.809</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPG at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPG at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPG at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.130</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPG at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.870</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPG at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.864</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPG at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.997</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPG at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.682</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPG at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.798</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPG at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.730</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPG at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPG at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPI at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.464</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPI at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.634</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPI at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.254</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPI at 30 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.034</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPI at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.765</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPI at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.434</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPI at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.184</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPI at 60 minutes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.142</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day for change from Baseline in PPI at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.955</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day for change from Baseline in PPI at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.985</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day for change from Baseline in PPI at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.923</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day for change from Baseline in PPI at 2 hour.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.883</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Glycosylated Hemoglobin A (HbA1c) Levels on Day 28</title>
        <description>The sample for HbA1c assessment was collected on Day 28. HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months.</description>
        <time_frame>Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Glycosylated Hemoglobin A (HbA1c) Levels on Day 28</title>
          <description>The sample for HbA1c assessment was collected on Day 28. HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.18" spread="0.95"/>
                    <measurement group_id="O2" value="8.66" spread="1.00"/>
                    <measurement group_id="O3" value="8.64" spread="0.93"/>
                    <measurement group_id="O4" value="8.54" spread="1.16"/>
                    <measurement group_id="O5" value="8.29" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.118</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.119</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.293</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.966</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HbA1c Levels at Day 28</title>
        <description>HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months. The sample for HbA1c assessment was collected on Day 1 and Day 28. Baseline value was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
        <time_frame>Baseline (Day 1) and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HbA1c Levels at Day 28</title>
          <description>HbA1c is used to show how well their diabetes is being controlled in participants with diabetes. The HbA1c test gives the average blood glucose levels over the pervious two to three months. The sample for HbA1c assessment was collected on Day 1 and Day 28. Baseline value was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="38"/>
                <count group_id="O5" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.31" spread="0.55"/>
                    <measurement group_id="O2" value="-0.23" spread="0.68"/>
                    <measurement group_id="O3" value="-0.05" spread="0.52"/>
                    <measurement group_id="O4" value="0.01" spread="0.78"/>
                    <measurement group_id="O5" value="-0.10" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.940</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.197</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.097</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.404</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC From Time 0 to 1 h (AUC 0-1) and AUC From Time 0 to 2 h (AUC 0-2) for PPG and PPI at Day 1 and Day 28</title>
        <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minnutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. AUC with respect to these time interval was calculated using the linear trapezoidal rule by the sum of the areas between each chronological pair of assessments (using observed times) for PPG and PPI.</description>
        <time_frame>Day 1 (30 minutes, 60 minutes and 2 hour) and Day 28 (30 minutes, 60 minutes and 2 hour)</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC From Time 0 to 1 h (AUC 0-1) and AUC From Time 0 to 2 h (AUC 0-2) for PPG and PPI at Day 1 and Day 28</title>
          <description>The assessment of PPG and PPI was performed at 30 minutes, 60 minnutes and 2 hour after the participant consumed the standardized meal (morning breakfast) on Day 1 and Day 28. AUC with respect to these time interval was calculated using the linear trapezoidal rule by the sum of the areas between each chronological pair of assessments (using observed times) for PPG and PPI.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mmol*hour per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="32"/>
                <count group_id="O4" value="31"/>
                <count group_id="O5" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, AUC 0-1, PPG</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="29"/>
                    <count group_id="O4" value="25"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.10" spread="2.69"/>
                    <measurement group_id="O2" value="14.08" spread="3.40"/>
                    <measurement group_id="O3" value="14.28" spread="3.50"/>
                    <measurement group_id="O4" value="14.43" spread="4.18"/>
                    <measurement group_id="O5" value="12.68" spread="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-1, PPG</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="25"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.35" spread="2.45"/>
                    <measurement group_id="O2" value="12.52" spread="2.41"/>
                    <measurement group_id="O3" value="13.25" spread="2.58"/>
                    <measurement group_id="O4" value="12.92" spread="2.27"/>
                    <measurement group_id="O5" value="11.33" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, AUC 0-2, PPG</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="27"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.39" spread="5.72"/>
                    <measurement group_id="O2" value="29.35" spread="7.64"/>
                    <measurement group_id="O3" value="29.87" spread="7.20"/>
                    <measurement group_id="O4" value="29.95" spread="9.34"/>
                    <measurement group_id="O5" value="26.07" spread="5.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-2, PPG</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.89" spread="5.84"/>
                    <measurement group_id="O2" value="25.98" spread="5.64"/>
                    <measurement group_id="O3" value="28.30" spread="5.51"/>
                    <measurement group_id="O4" value="27.01" spread="5.11"/>
                    <measurement group_id="O5" value="24.14" spread="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, AUC 0-1, PPI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="26"/>
                    <count group_id="O5" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192.4" spread="121.08"/>
                    <measurement group_id="O2" value="211.1" spread="245.53"/>
                    <measurement group_id="O3" value="176.6" spread="105.51"/>
                    <measurement group_id="O4" value="168.3" spread="123.33"/>
                    <measurement group_id="O5" value="186.0" spread="92.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-1, PPI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="27"/>
                    <count group_id="O4" value="27"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212.1" spread="176.25"/>
                    <measurement group_id="O2" value="207.1" spread="202.43"/>
                    <measurement group_id="O3" value="168.1" spread="135.71"/>
                    <measurement group_id="O4" value="138.8" spread="120.34"/>
                    <measurement group_id="O5" value="164.6" spread="175.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, AUC 0-2, PPI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="26"/>
                    <count group_id="O4" value="28"/>
                    <count group_id="O5" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="423.8" spread="289.68"/>
                    <measurement group_id="O2" value="478.8" spread="584.46"/>
                    <measurement group_id="O3" value="418.4" spread="251.25"/>
                    <measurement group_id="O4" value="377.6" spread="297.27"/>
                    <measurement group_id="O5" value="385.8" spread="167.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, AUC 0-2, PPI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="26"/>
                    <count group_id="O3" value="27"/>
                    <count group_id="O4" value="29"/>
                    <count group_id="O5" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="444.8" spread="332.82"/>
                    <measurement group_id="O2" value="477.7" spread="538.49"/>
                    <measurement group_id="O3" value="394.5" spread="276.65"/>
                    <measurement group_id="O4" value="334.7" spread="256.51"/>
                    <measurement group_id="O5" value="381.3" spread="378.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-1 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2060</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-1 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1790</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-1 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2741</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-1 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6001</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-1 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6711</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-1 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.1361</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-1 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3369</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-1 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0975</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-2 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2184</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-2 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1013</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-2 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3286</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-2 at Day 1 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5193</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-2 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9788</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-2 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1214</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-2 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5751</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-2 at Day 28 for PPG.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2409</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-1 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4829</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-1 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7563</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-1 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2907</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-1 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7663</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-1 at Day 28 for PPI</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5825</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-1 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3220</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-1 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0564</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-1 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1960</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-2 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5997</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-2 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9637</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-2 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3240</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-2 at Day 1 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8440</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day of AUC 0-2 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6483</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day of AUC 0-2 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6452</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day of AUC 0-2 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1253</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day of AUC 0-2 at Day 28 for PPI.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2583</p_value>
            <p_value_desc>No adjustments for covariates were made.</p_value_desc>
            <method>Wilcoxon test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Fructosamine Levels at Day 1 and Day 28</title>
        <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28.</description>
        <time_frame>Day 1 and Day 28</time_frame>
        <population>ITT Population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Fructosamine Levels at Day 1 and Day 28</title>
          <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28.</description>
          <population>ITT Population.</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="320.07" spread="61.28"/>
                    <measurement group_id="O2" value="320.38" spread="49.20"/>
                    <measurement group_id="O3" value="319.82" spread="56.73"/>
                    <measurement group_id="O4" value="328.44" spread="62.90"/>
                    <measurement group_id="O5" value="296.00" spread="41.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="305.70" spread="56.04"/>
                    <measurement group_id="O2" value="315.97" spread="60.46"/>
                    <measurement group_id="O3" value="330.15" spread="61.32"/>
                    <measurement group_id="O4" value="318.63" spread="50.90"/>
                    <measurement group_id="O5" value="285.28" spread="57.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 1 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 1 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 1 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.901</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 1 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.155</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 28 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.845</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 28 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.164</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 28 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.699</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 28 for fructosamine.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.313</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Fructosamine Levels at Day 28</title>
        <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
        <time_frame>Baseline (Day 1) and Day 28</time_frame>
        <population>ITT Population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Fructosamine Levels at Day 28</title>
          <description>Fructosamine (a glycated protein) level enables assessment of long-term glycemic control in participants with diabetes mellitus. The blood samples for fructosamine assessment was obtained at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
          <population>ITT Population.</population>
          <units>mmol per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.37" spread="41.18"/>
                    <measurement group_id="O2" value="-6.67" spread="40.27"/>
                    <measurement group_id="O3" value="9.76" spread="62.77"/>
                    <measurement group_id="O4" value="-4.68" spread="44.64"/>
                    <measurement group_id="O5" value="-2.14" spread="48.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.896</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.080</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.792</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.645</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Homeostatic Model Assessment-insulin Resistance (HOMA-IR) at Day 1 and Day 28</title>
        <description>HOMA-IR was derived from FPG and FPI as: FPI (micro units [mU]/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
        <time_frame>Day 1 and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Homeostatic Model Assessment-insulin Resistance (HOMA-IR) at Day 1 and Day 28</title>
          <description>HOMA-IR was derived from FPG and FPI as: FPI (micro units [mU]/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mU*mmol per liter^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="3.98"/>
                    <measurement group_id="O2" value="5.7" spread="5.45"/>
                    <measurement group_id="O3" value="5.2" spread="5.20"/>
                    <measurement group_id="O4" value="4.1" spread="3.31"/>
                    <measurement group_id="O5" value="5.0" spread="3.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="3.56"/>
                    <measurement group_id="O2" value="5.9" spread="7.28"/>
                    <measurement group_id="O3" value="3.9" spread="2.55"/>
                    <measurement group_id="O4" value="4.0" spread="3.66"/>
                    <measurement group_id="O5" value="5.9" spread="10.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 1 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.992</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 1 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 1 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.548</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 1 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 28 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.877</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 28 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.887</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 28 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.916</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 28 for HOMA-IR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.860</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HOMA-IR at Day 28</title>
        <description>HOMA-IR was derived from FPG and FPI as: FPI (mU/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
        <time_frame>Baseline (Day 1) and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 minutes following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HOMA-IR at Day 28</title>
          <description>HOMA-IR was derived from FPG and FPI as: FPI (mU/mL)*FPG (mmol per liter) divided by 22.5. HOMA-IR was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>mU*mmol per liter^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="3.61"/>
                    <measurement group_id="O2" value="0.0" spread="7.26"/>
                    <measurement group_id="O3" value="-0.9" spread="3.47"/>
                    <measurement group_id="O4" value="-0.1" spread="3.83"/>
                    <measurement group_id="O5" value="1.0" spread="10.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.996</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.989</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.763</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean HOMA-percentage Cell Beta Function at Day 1 and Day 28</title>
        <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
        <time_frame>Day 1 and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean HOMA-percentage Cell Beta Function at Day 1 and Day 28</title>
          <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Percentage of beta cell function</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.3" spread="38.15"/>
                    <measurement group_id="O2" value="31.8" spread="46.38"/>
                    <measurement group_id="O3" value="31.2" spread="35.46"/>
                    <measurement group_id="O4" value="27.2" spread="21.39"/>
                    <measurement group_id="O5" value="30.2" spread="23.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.9" spread="34.71"/>
                    <measurement group_id="O2" value="42.9" spread="57.90"/>
                    <measurement group_id="O3" value="32.6" spread="34.57"/>
                    <measurement group_id="O4" value="28.4" spread="26.48"/>
                    <measurement group_id="O5" value="40.9" spread="48.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 1 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.810</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 1 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.753</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 1 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.404</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 1 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.671</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.25 g/day at Day 28 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 0.5 g/day at Day 28 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.622</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 1.0 g/day at Day 28 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.332</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Placebo versus SRT2104 2.0 g/day at Day 28 for HOMA-percentage of beta cell function.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.998</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HOMA-percentage of Beta Cell Function at Day 28</title>
        <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as assessment done on Day 1. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
        <time_frame>Baseline (Day 1) and Day 28</time_frame>
        <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O2">
            <title>SRT2104 0.25 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O3">
            <title>SRT2104 0.5 g/Day</title>
            <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O4">
            <title>SRT2104 1.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
          <group group_id="O5">
            <title>SRT2104 2.0 g/Day</title>
            <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HOMA-percentage of Beta Cell Function at Day 28</title>
          <description>HOMA-percentage cell beta function was derived from FPG and FPI as: 20*FPI (mU/mL) divided by FPG (mmol per liter) minus 3.5. HOMA-percentage cell beta function was calculated from the Day 1 and Day 28 FPG and FPI values at Day 1 and Day 28. Baseline was defined as assessment done on Day 1. Baseline was defined as the assessment done on Day 1. The change from Baseline was calculated by subtracting the Baseline value (Day 1) from the individual post-Baseline (Day 28) value.</description>
          <population>ITT Population. Only those participants available at the specified time points were analyzed.</population>
          <units>Percentage of beta cell function</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="34.02"/>
                    <measurement group_id="O2" value="8.5" spread="42.09"/>
                    <measurement group_id="O3" value="2.3" spread="17.87"/>
                    <measurement group_id="O4" value="3.1" spread="26.45"/>
                    <measurement group_id="O5" value="7.6" spread="51.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.994</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.979</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.993</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis was performed using ANOVA with Dunnett’s test using the placebo group as the control, a 2-sided alpha of 0.05 was set as the significance threshold. No adjustments for covariates were made.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Dunnett’s test was used to control for inflation of alpha due to multiple comparisons, using the placebo group as the control.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AE's and SAE's were collected from the start of study medication (Day 1) up to Follow-up (58 days)</time_frame>
      <desc>Safety Analysis Set Population was used.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Participants received oral dose of matching placebo to SRT2104 capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="E2">
          <title>SRT2104 0.25 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.25 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="E3">
          <title>SRT2104 0.5 g/Day</title>
          <description>Participants received oral dose of SRT2104 0.5 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="E4">
          <title>SRT2104 1.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 1.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
        <group group_id="E5">
          <title>SRT2104 2.0 g/Day</title>
          <description>Participants received oral dose of SRT2104 2.0 g/day capsule, once daily for 28 consecutive days. The study medication was administered as 8 capsules per day to maintain the blinding, at the same time every morning, approximately 15-30 min following the start of meal consumption with 1 to 2 glasses of water.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 13.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 13.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

